Archives

AMTZ Joined Hand With Paytm To Enable Cashless Transaction For Entire Zone Of AMTZ

AMTZ partners with Paytm and further strengthen the vision of PM Sh. Narendra Modi

AMTZ the ultra-modern manufacturing hub for medical devices production added a feather in its cap by aiming to become the first cashless economic zone in the country. AMTZ on 8th July signed a Memorandum of Understanding (MoU) with One97 Communications Limitedwhich owns and operatesthe Paytm online platform and the Paytm app.The MoU with Paytm shall help enable cashless transactions for the entire zone of AMTZ including scientific tests and works, trading, payments for general and social services.

AMTZ which came into being on 19th Aug 2016 with the foundation laying ceremony has been on top of strategy and operations with several manufacturing units bee-lining into a basket of one of its scientific infrastructure. Paytm which has soared into public appeal with demonetization drive is country’s most population digital transaction portal. The MoU between AMTZ and Paytm is first of its kind partnership between an industrial hub and a transaction platform.

AMTZ holds training programme on quality certification for medical devices manufacturers

The Andhra Pradesh MedTech Zone (AMTZ), India’s first state-of-the-art medical devices manufacturing park in Visakhapatnam, organised a two-days industry training programme on quality certification with an aim to bring down the time and cost-run to obtain globally accepted quality certification for Indian manufacturers.

The training programme, held on 28th and 29th June and attended by medical devices manufacturers, medical professionals and other industry stakeholders, was organised in association with Quality Council of India (QCI), National Accreditation Board for Certification Bodies (NABCB) and Association of Indian Medical Device Industry (AIMED).

The programme mainly focused on helping medical device manufacturers understand EC (European Commission) regulations, CE (Conformité Européene) marking, Industry Indian Certification for Medical Devices (ICMED) certification and New Medical Device Rules, 2017.

The programme’s objective was to fill the regulatory space in quality certification for medical devices in the country. The key themes of the training sessions included EU regulatory, medical device definition and risk classification; CE Marking and New MDR; ICMED 9000 certification, which is ISO 9001 plus additional requirements; ICMED 13485, which is ISO 13485 plus additional requirements; and New Medical Device Rules, 2017.

Thanking QCI and NABCB for organising the event jointly “to exchange the knowledge share of regulations and application process for the medical device”, Dr Jitendar Kumar Sharma, CEO and Director, AMTZ, said: “With this event, we will aim to create a more progressive practice towards regulatory frame work in the medical device sector.”

Mrutunjay Jena, Joint Director, QCI, said, “QCI & AIMED in partnership with AMTZ is initiating a number of voluntary awareness Programs to facilitate industry and demonstrate compliance to the best global standards of which ICMED is one of them.”

AMTZ INKS PACT WITH COMMON SCIENTIFIC FACILITIES SERVICE PROVIDERS

AndhraPradesh MedTech Zone (AMTZ) on June 16, 2017 concretised formal agreements with the various scientific facilities which shall be within the country’s first Medical Technology Manufacturing Park spread over 270 acre. These facilities include: Centre for Electro-Magnetic Interference / Electro-Magnetic Compatibility (EMI/EMC) and Electrical Safety Testing (EST), Centre for Biomaterials Testing, Centre for X-ray & CT Scan Tube Manufacturing, Centre for 3D Designing, canning, Printing, Rapid Prototyping & Tooling, Centre for Gamma Irradiation and AMTZ Central Warehouse.

AMTZ shall be partnering with TÜV Rheinland India for the EMI/EMC & EST as well as the Biomaterials Testing Facilities; CURA Healthcare Pvt. Ltd. for the Centre for X-ray & CT Scan Tube Manufacturing; think3D for the Centre for 3D Designing, canning, Printing, Rapid Prototyping & Tooling; MICROTROL Sterilisation Services Pvt. Ltd. for the Gamma Irradiation Centre and Balmer Lawrie & Co. Limited for the Central Warehouse.

TÜV Rheinland India, a subsidiary of TÜV Rheinland Group, Germany, a worldwide leader in Testing, Training, Inspection, Consulting & Certification was represented by Mr. Thomas Fuhrmann, Managing Director, TÜV Rheinland India.CURA Healthcare Pvt. Ltd. was represented by its CEO, Mr. M. Balasubramaniam; Mr. Prudhvi Reddy, Co-founder, think3D; Mr. Vikram B. Kalia, Director, MICROTROL Sterilisation Services Pvt. Ltd. and Mr. K. Swaminathan, Director (Service Businesses), Balmer Lawrie & Co. Ltd. were present at the said event.While agreement signing kick-starts a series of technical works, a formal exchange of this agreement is shortly scheduled at a high-level event.

Complementing the above-mentioned ecosystem, AMTZ has firmed up strategic tie-ups with Industry Associations including Association of Indian Medical Device Industry, Andhra Chamber of Commerce, GMDN Agency, India Angel Network, PHD Chamber of Commerce and Industry, Quality Council of India, UNITED ASIA and World Association for Small and Medium Enterprises; BIORx Venture Advisors Private Limited, HDFC Bank&NTrust Insurance Broking Services for Financial & Specialised Insurance services; Cerner Healthcare Solutions, Hibiscus Consulting, IZiel Healthcare, MarksMan Healthcare Solutions, Meshayu Consultants Private Limited, National Hub for Healthcare Instrumentation Development(NHHID), Operon Strategist and PC Process for Technology Transfer & Regulatory Consulting; monster.com for Human Resource facilitation and eLets Technomedia Pvt.Ltd., Medgate today Magazine and BMJ Noida as media partners. Along with this AMTZ has also launched bookings of office space for manufacturers.

Hyd-based Think3D to set up 3D printing facility at Andhra Pradesh Medtech Zone

The facility will be operational in a year’s time and will be the first of its kind to operate all services under one roof in PPP mode.

Think3D, a Hyderabad-based 3D printing solutions company, has bagged the contract to set up and operate a world-class 3D printing facility at the Andhra Pradesh Medtech Zone Limited (AMTZ).

AMTZ is a prestigious medical devices manufacturing park being developed by the Andhra Pradesh government.

AMTZ signed an agreement for the construction, operation, management and maintenance of the 3D designing and printing facility, prototyping and rapid tooling at AMTZ on a PPP basis.

The scientific facility to be setup will be equipped with a range of 3D printing and other fabrication technologies, a maker lab for innovators and a 3D design facility for developing concepts to reality, the company said in a statement.

With an investment of $6 million and spread over an acre, the facility will be operational in a year’s time and will be the first of its kind to operate all services under one roof in the Public Private Partnership mode.

Think3D is a 3D printing solutions company which has it presence across 11 cities, over 50 brands and has 1000+ customers.

It provides services like 3D printing and prototype services where it build a full-fledged product with a 3D printer.

It supplies all kinds of 3D hardware like 3D printers, 3D scanners, and consumables with a dedicated support team to handle all post-sale requests.

It works in the medtech space where it provides various medical 3D printing solutions like pre-surgical aids, surgical guides & implants.

It also helps train students and conducts courses and workshops on 3D printing.

Think3D to set up facility at Andhra Medtech Zone

Think3D, a Hyderabad-based 3D printing solutions company, has bagged the contract to set up and operate a world-class 3D printing facility at the Andhra Pradesh Medtech Zone Limited (AMTZ).

AMTZ is a prestigious medical devices manufacturing park being developed by the Andhra Pradesh government.

AMTZ signed an agreement for the construction, operation, management and maintenance of the 3D designing and printing facility, prototyping and rapid tooling at AMTZ on a PPP basis.

The scientific facility to be setup will be equipped with a range of 3D printing and other fabrication technologies, a maker lab for innovators and a 3D design facility for developing concepts to reality, the company said in a statement.

With an investment of $6 million and spread over an acre, the facility will be operational in a year’s time and will be the first of its kind to operate all services under one roof in the Public Private Partnership mode.

Think3D to set up facility in Andhra Pradesh

Hyderabad: Think3D, a city-based 3D printing solutions company, has bagged the contract to set up and operate a world-class 3D printing facility at the Andhra Pradesh Medtech Zone Limited (AMTZ). AMTZ is a prestigious medical devices manufacturing park being developed by the Andhra Pradesh government.

AMTZ signed an agreement for the construction, operation, management and maintenance of the 3D designing and printing facility, prototyping and rapid tooling at AMTZ on a PPP basis.

The scientific facility to be setup will be equipped with a range of 3D printing and other fabrication technologies, a maker lab for innovators and a 3D design facility for developing concepts to reality, the company said in a statement.

With an investment of $6 million and spread over an acre, the facility will be operational in a year’s time and will be the first of its kind to operate all services under one roof in the Public Private Partnership mode.

Think3D to open facility at Andhra Pradesh medical devices park

HYDERABAD: Three-dimensional printing solutions provider Think3D will be setting up a 3D printing facility in collaboration with Andhra Pradesh Medtech Zone (AMTZ) with an investment of $6 million, announced a top company executive.

The facility, to come up on an area of 20,000 sft, will offer prototyping and low volume manufacturing to medical devices companies in AMTZ.

Prudhvi Reddy, co-founder, Think3D said, “The facility will come up on an area of 17,000-20,000 sft in the first phase and then look at expanding in the remaining land of the one acre that has been allotted to us. While the infrastructure would be taken care of by the government, sourcing of devices and upkeep of the facility would be the responsibility of the company. We will be catering to over 400 companies including X-ray manufacturers at the park”.

The profit sharing ratio between AMTZ and Think3D is 70:30 which could change depending on the future investments made by each of the players, said a senior executive of Think3D seeking anonymity.

AMTZ, is an enterprise under the Andhra Pradesh government, a 270 Acre zone, dedicated for medical devices manufacturing and aims to reduce the cost of manufacturing by up to 40Rs and also reduce dependency on imports for medical devices, which is presently around 78Rs .

Co-founder of think3D tells us more about $6 million 3D Printing facility for medical devices

A $6 million state-of-the-art 3D printing facility is planned for the the city Visakhapatnam in India. Also known as Vizag, the city is the financial capital of the Indian state of Andhra Pradesh.

The additive manufacturing center will be built under an agreement between Andhra Pradesh MedTech Zone (AMTZ) and think3D. Raja Sekhar Upputuri is the co-founder of think3D who operate in 11 cities across the country. With over 1,000 customers think3D is India’s largest 3D printing platform.

AMTZ (AP Medical Tech Zone) is an SPV formed by the Indian government and the provincial government of Andhra Pradesh to promote medical device manufacturing in India and reduce dependence on imports for medical devices.

The 200 acre region where the $6 million 3D printing AMTZ facility will be set up photo via think3d and amtz
The 200 acre region where the $6 million 3D printing AMTZ facility will be set up photo via think3d and amtz

Addressing a $5.5 billion market

3D Printing Industry asked Raja Sekhar Upputuri a few questions about the plans.

“Currently the land development works are going on,” says the think3D co-founder. “Our facility and a few manufacturing companies should be open by October 2018. For full fledged activity in the park, it would easily take another 3-4 years.”

Vizag has the tenth largest economy in India. The planned 3D printing facility is intended to address the $5.5 billion Indian medical market, a figure that is expected to grow substantially in coming years. Currently approximately 75% of demand is met by imports. This means that the price of medical devices can fluctuate with currency movements, furthermore by importing the devices an opportunity to create jobs in the country is missed.

As previously reported by 3D Printing Industry, several countries are also establishing specialist medical 3D printing centers.

The global medical device market. Image via AMTZ
The global medical device market. Image via AMTZ

3D printing supports best-in-class manufacturing infrastructure

The $6 million facility is part of the central government’s “MAKE IN INDIA” project, a major national initiative designed to foster innovation and build a best-in-class manufacturing infrastructure.

The project provides an insight into the potential of 3D printing for Newly Industrialized Countries to leapfrog a development stage and move directly to advanced manufacturing. According to think3D,

Medical device manufacturing requires huge up-front investment in R&D, machinery and QC facilities. Some of these facilities have very little utilization rate but are required as part of the manufacturing process. Taking this into consideration, the government has decided to set-up these common facilities in partnership with private entities and offer these facilities to manufacturers within park on pay per use basis thus reducing the upfront investment from manufacturer cost drastically. 3D Printing & 3D design facility is chosen as one such common facility.
Prudhvi Raj, co-founder think3D signing contract with AMTZ for the $6 million medical 3D printing facility.
Prudhvi Raj, co-founder think3D signing contract with AMTZ for the $6 million medical 3D printing facility.

Come with an idea, leave with the finished prototype

Raja Sekhar Upputuri tells us that the facility will employ between 50 to 60 people. Work is underway to determine the 3D printing technology requirements, as he says,

We haven’t yet zeroed in on brands. As for types of machines, we definitely will have 1 metal 3D Printer, 2 – 3 SLS 3D Printers, a few SLA / DLP machines, many FDM machines, a few high end scanners like Artec, Faro. We also will have 1 or 2 CNC Machines, Vacuum casting machines as for some prototypes we need to employ traditional methods.
In additional to 3D printing, the 20,000 sq ft space will include state of-art reverse engineering facility and an expert 3D design facility. The intent is that, “manufacturers can come to the facility with just an idea and leave with the finished prototype.”

Raja Sekhar Upputuri also told us more about how 3D printing will be used in production of medical devices.

3D Printing will be used for prototype and batch production of few parts for medical devices. For example MRI, ECG, Ultrasound machines, different types of syringes and so on. TUV Rhineland is setting up a testing center in the facility to thoroughly test these devices before they are launched in the market.
The aforementioned TUV Rhineland deal is a partnership with Andhra Pradesh MedTech Zone (AMTZ). Under a public private partnership (PPP) – estimated at $13 million – the testing facilities will also be established in the region.

Dr. Jithendra Sharma, CEO AMTZ, explains, “We realized the need to have mega industrial partners in AMTZ. They will support manufacturers in producing quality product at an industrial cost-effective scale.”

The Andhra Pradesh MedTech Zone is India’s first manufacturing park specialising in medical technology, the zone will occupy 270 acres.

AMTZ, think3D announce $6M medical device 3D printing facility in India

Jun 19, 2017 | By Tess

Indian 3D printing platform think3D, a subsidiary of Singapore-based think3D Labs Pte Ltd., has announced it will be establishing a $6 million 3D printing facility in Vizag, Andhra Pradesh, India. The center is being realized in collaboration with the Andhra Pradesh MedTech Zone (AMTZ), a special-purpose entity formed by the Indian government and the Andhra Pradesh provincial government with the goal of advancing medical device manufacturing in the country.

The $6 million facility is expected to enable India’s medical device market (worth $5.5 billion and on the rise) to become more independent. Currently, nearly 75% of the market is made up of imported devices, a reality which hinders the country’s economy and employment growth.

Part of the effort to increase medical device manufacturing in India is coming from MAKE IN INDIA, a government-led initiative aimed at promoting and expanding Indian design and manufacturing on the whole. Together with the government of Andhra Pradesh, MAKE IN INDIA has launched India’s first medical technology manufacturing park and is encouraging local manufacturers to use its facilities with the support of subsidies.

At the park, one facility will be dedicated to 3D printing and 3D design. There, manufacturers in India will be able to benefit from state-of-the-art additive manufacturing equipment on a pay-per-use basis. This method will allow businesses to bypass large investments in equipment and their own manufacturing facilities without having to sacrifice high-end technologies.

“We realized the need to have mega industrial partners in AMTZ,” says Dr. Jithendra Sharma, CEO of AMTZ. “They will support manufacturers in producing quality product at an industrial cost-effective scale.”

Visit to the AMTZ site

think3D was chosen to help AMTZ set up and manage the 3D Printing & 3D Design facility after submitting a tender. Through the tender agreement, AMTZ will provide think3D with equipment through the facility on lease, while think3D will use its own expenses to manage the facility, offering services to customers at a subsidized rate (or at market rate for non-park customers).

The facility itself will span 20,000 square feet and will feature a number of metal, SLS, SLA, and bio 3D printers, as well as a reverse engineering facility and 3D design tools. “We are very excited to be part of AMTZ facility and contribute to the MAKE IN INDIA initiative,” said Raja Sekhar Upputuri, co-founder of think3D. “A state-of-art 3D printing & 3D designing facility helps manufacturers bring innovative products into the market at a much faster pace. We look forward to see some great medical devices coming out of this park in years to come.”

“think3D got selected in the tendering process by winning both technical and financial bids,” added Nitin Bharadwaj, Vice President of Operations at AMTZ Ltd. “We believe think3D is a perfect partner for us to manage the 3D facility in the park. We were looking for one entity having expertise in 3D design, 3D scanning, and 3D printing fields and think3D fits the bill perfectly. We have seen various case studies they executed and are very excited about the value they bring to the park.”

According to market intelligence solutions firm 6Wresearch, India’s 3D printing market is expected to reach $62 million by the year 2022.

think3D Tapped by Provincial Indian Government to Open 3D Printing and Design Facility in Medical Device Park

India-based think3D, the largest desktop 3D printing platform in the country, has been around since 2014. Since it opened its doors, the organization, which is a subsidiary of Singapore-based think3D Labs Pte Ltd, has presented a 3D printing art exhibit at an international school, supplied 3D printed models for an initiative with India’s Devnar Foundation for the Blind, helped several engineering students test out their newly developed metal 3D printer, and last year unveiled its new mobile app for Android. Recently, think3D won a government tender to set up a new 3D printing facility in India.

Render via AMTZ showing advanced manufacturing facilities; may depict the UK’s AMP
The $6 million state-of-the-art facility in Vizag will be developed in partnership with the provincial Indian government of Andhra Pradesh, which is the eighth largest state in India. The facility will be part of a new medical devices park, the Andhra Pradesh Medical Tech Zone (AMTZ), which is an SPV formed by the Andhra Pradesh government and the Indian government to reduce the country’s dependence on imported medical devices and promote this type of manufacturing within India. The medical device manufacturing zone is roughly 270 acres.
“We realized the need to have mega industrial partners in AMTZ,” said Dr. Jithendra Sharma, the CEO of AMTZ. “They will support manufacturers in producing quality product at an industrial cost-effective scale.”
The medical device market in India is worth $5.5 billion, and huge growth is expected in the next several years. However, nearly 75% of the market is made up of imported medical devices, which means a monetary and employment loss for the country. The AMTZ park was founded to encourage medical device manufacturers to set up shop in India, as part of the central government’s Make In India initiative, which was launched two years ago as a means of transforming the country into a global manufacturing and design hub.

Prudhvi Raj, co-founder of think3D, signing contract with AMTZ
A substantial up-front investment is required for medical device manufacturing, in order to pay for research and development efforts, quality control, and quality machinery facilities. Some facilities, while a required part of the manufacturing process, do not have much of a utilization rate, which is why the government in India made the decision to partner up with private entities to break ground on common facilities, and allow manufacturers in the AMZT park the option to use the 3D printing manufacturing and design facility on a pay-per-use basis, which lowers the manufacturer’s up-front cost significantly.

200-acre region where AMTZ facility will be set up
A tender was floated to choose a private entity to work with AMTZ to set up and manage the 3D printing and design facility at the park, and after a long technical and financial evaluation, think3D was chosen.
“As per government rules, we floated a tender for an entity to set-up and manage day-to-day operations at the facility. think3D got selected in the tendering process by winning both technical and financial bids,” explained Nitin Bharadwaj. Vice President, Operations, AMTZ Ltd. “We believe think3D is a perfect partner for us to manage the 3D facility in the park. We were looking for one entity having expertise in 3D Design, 3D Scanning & 3D Printing fields and think3D fits the bill perfectly. We have seen various case studies they executed and are very excited about the value they bring to the park.”
think3D will set up and manage, as part of its agreement with AMTZ, a 20,000-square-foot rapid prototyping facility, an expert 3D design facility, and a reverse engineering facility; the rapid prototyping facility will house various high-quality metal 3D printers for any SLS, SLA, and bioprinting needs. AMTZ will purchase the 3D printers, and lease both the facility and the machinery to think3D, which will manage the whole operation at its own expense while offering 3D printing customers at the park a subsidized pay-per-use rate; a market rate will be available for any entities outside of the park.

“We are very excited to be part of AMTZ facility and contribute to the MAKE IN INDIA initiative,” said Raja Sekhar Upputuri, think3D Co-Founder. “A state-of-art 3D printing & 3D designing facility helps manufacturers bring innovative products into the market at a much faster pace. We look forward to see some great medical devices coming out of this park in years to come.”
When government and 3D printing mix, things can definitely take a positive turn in the manufacturing and education sectors – just look at everything that’s been accomplished since the Dubai 3D Printing Strategy was established. But this isn’t always the case, so it will be interesting to see what comes of the AMTZ and think3D partnership. Discuss in the think3D forum at 3DPB.com.

TUV Rheinland partners with AP MedTech Zone to set up testing unit investing Rs 85 crore

Our Bureau, Bengaluru
Monday, June 19, 2017, 15:00 Hrs [IST]
TUV Rheinland India, a subsidiary of TUV Rheinland Group, Germany, a global leader in Testing, Training, Inspection, Consulting & Certification has partnered with Andhra Pradesh MedTech Zone (AMTZ), the country’s first Medical Technology Manufacturing Park at Visakapatnam. The company will set up a test facility here investing around Rs. 85crore.

As per the terms of the partnership, TUV Rheinland India has been awarded a contract to set up and operate Electro-Magnetic Interference (EMI/EMC) including Anechoic Chambers, Biomaterial, Reliability & Electrical Safety Testing Facilities on Public Private Partnership Mode within AMTZ at an estimated investment of about Rs 85 crore over 4-5 years to support AMTZ’s objective to reduce medical device imports and production cost, partner with industry to deliver the quality medical devices to local market and eventually increase the export of world class medical devices to the international market.

The contract was inked by Thomas Fuhrmann, Managing Director,TUV Rheinland India and Dr. Jitendar Kumar Sharma, Director & CEO of AMTZ. While agreement signing kick-starts a series of technical works, a formal exchange of this agreement is shortly scheduled at a high level event.

AMTZ will house modern 250-300 independent manufacturing units,each over a built-in ready to use area at a very cost effective long-term lease. In addition the park will have in-house high investment scientific facilities, including state-of-the-art testing laboratories, which would help manufacturers significantly reduce the cost manufacturing thereby creating world class diagnosis with quality products accessible to the common man at affordable prices.

“We are honoured that AMTZ has selected TUV Rheinland as its partner to establish testing laboratories within the zone and assist in its ‘Make In India’ drive”, said Thomas Fuhrmann, Managing Director, TUV Rheinland India.

“This is a result of our rich expertise and experience in supporting local and multinational medical device manufacturers in their verification & validation, equipment testing and certification activities,” he added.
“As AMTZ is investing on infrastructure and test equipment, it is evident that TUV Rheinland will have a very special price for the Medical device manufacturers within the zone. Also as these world class test facilities are within the zone, Medical device manufacturers can use the labs that are available in next door. This would reduce the overall product developmental lifecycle, logistics charges and turnaround time to market,” said Kalyan Varma, Vice President Products, TUV Rheinland India.

TUV Rheinland along with other scientific labs within the Zone can act as one-stop solution for the manufacturers within the zone to have their products tested and certified as per the newly published medical devices rules 2017 which will come into force from 1st Jan 2018, he added.

TUV Rheinland, State ink pact

Medical devices testing lab to be set up in MedTech Zone

The Medical Devices Park that is coming up in the district will have about 250-300 medical devices manufacturing units, according to Jitendra Kumar Sharma, CEO of Andhra Pradesh MedTech Zone (AMTZ).

He was speaking at the signing of an MoU between the State government and TUV Rheinland (India) Private Limited, an Indian subsidiary of the German firm, here on Friday.

“There is immense potential for import substitution, and at a later stage for exports also, of medical devices in India as 80% of the devices are being imported at present, said Thomas Fuhrmann, CEO and MD of TUV Rheinland (India) Private Limited. TUV will be setting up a medical devices testing lab in the Medical Devices Park, which is coming up in an extent of 270 acres. Mr. Fuhrmann further said his company had been awarded the contract to set up and operate the laboratory with facilities for testing electro-magnetic interference (EMI/EMC), anechoic chambers, bio-material reliability and electrical safety. “The State government would provide the land, two acres or so, in the park and we have to invest roughly about ₹100 crore on the lab,” he said.

He also lauded the efforts of the State government in setting up the park, which would give a great boost to the sector in the State and in the country.

Advantages

Vice-president of the company Kalyan Verma said: “Availability of world-class testing facilities within the Medical Devices Park will make it easier for the manufacturers to improve quality. It will reduce logistics cost and the manufacturers can get their products tested within the park in accordance with the new Medical Devices Rules, 2017, coming into force from January 1, 2018.” The testing lab would be ready by next year.

Andhra Pradesh ties up with TUV Rheinland to test medical devices

HYDERABAD: German technical services provider TUV Rheinland’s Indian subsidiary has partnered with Andhra Pradesh MedTech Zone (AMTZ) to create an infrastructure for Electro-Magnetic Interference (EMI/EMC) at an investment of Rs 85 crore over four to five years.

The public-private partnership is aimed at reducing the medical devices imports and production cost and to help deliver quality medical devices to local market.

Thomas Fuhrmann, managing director, TUV Rheinland India, said, “We have been selected by AMTZ for operation, management and maintenance of Electro-Magnetic Interference (EMI/EMC), electrical safety and biomaterial testing laboratories. These laboratories on a high level will have state-of-the facilities for testing of electrical and electronic products”.
The contract was signed on Friday by Thomas Fuhrmann and.Jitendar Kumar Sharma, director and chief executive officer (CEO), AMTZ.

“As AMTZ is investing on infrastructure and test equipment, it is evident that TUV Rheinland will have a very special price for the medical device manufacturers within the zone. Also, as these world class test facilities are within the zone, manufacturers can use the labs that are available. This would reduce the overall product developmental lifecycle, logistics charges and turnaround time to market,” said Kalyan Varma, vice-president, products, TUV Rheinland India.

He added that TUV Rheinland along with other scientific labs within the zone can act as one stop solution for the manufacturers within the zone to have their products tested and certified as per the newly published medical devices rules 2017 which will come into force from January 1, 2018.

Spread over an area of 270 acres, AMTZ will house 250-300 modern independent manufacturing units as it seeks to reduce the cost of manufacturing medical devices. With a market size of close to $4 Billion, 78% of medical devices in India are imported from other countries.

TUV Rheinland India to set up testing facilities in AMTZ

TUV Rheinland India, a global leader in testing, training, inspection, consulting and certification of medical devices, has joined hands with Andhra Pradesh MedTech Zone (AMTZ) to set up testing facilities in the country’s first medical technology manufacturing park on the public private partnership mode.

The subsidiary of TUV Rheinland Group, Germany, will invest about Rs 85 crores over a period of four-five years in the recently established medtech park at Visakhapatnam to help it achieve its objective of reducing medical device imports, production cost and partner with industry to deliver quality medical devices to local market, and eventually increase the export of world class medical devices to the international market.

The contract was signed on Friday by Thomas Fuhrmann, Managing Director of TUV Rheinland India and Dr Jitendar Kumar Sharma, Director and CEO of AMTZ. While agreement signing kick-starts a series of technical works, a formal exchange of this agreement is shortly scheduled at a high-level event.

“We are honoured that AMTZ has selected TUV Rheinland as its partner to establish testing laboratories within the zone and assist in it’s ‘Make In India’ drive”, said Fuhrmann.

“TUV Rheinland India has been selected by AMTZ for operation, management and maintenance of electro-magnetic interference (EMI/EMC), electrical safety and biomaterial testing laboratories. These laboratories on a high level will have state-of-the facilities for testing of electrical and electronic products including medical devices for EMI/EMC, electrical safety and biomaterial,” he added.

As AMTZ is investing on infrastructure and test equipment, it is evident that TUV Rheinland will have a very special price for the medical device manufacturers within the zone.

Also, as these world class test facilities are within the zone, medical device manufacturers can use the labs that are available in next door.

“This would reduce the overall product developmental lifecycle, logistics charges and turnaround time to market,” said Kalyan Varma, Vice President Products, TUV Rheinland India.

“TUV Rheinland along with other scientific labs within the zone can act as one-stop solution for the manufacturers within the zone to have their products tested and certified as per the newly published Medical Devices Rules 2017 which will come into force from 1st January 2018,” Varma added.

TUV Rheinland is the only certification body in India that boasts of an accredited welding institute offering welding courses to the industry in order to enhance the technical skills of its employees. The company has ambitious plans for setting up of laboratories in other parts of India as well in the near future.

AMTZ partners with GMDN Agency for identification of medical devices

Attracting attention of medical device fraternity across the world, the Andhra Pradesh MedTech Zone (AMTZ) recently joined the Global Medical Device Nomenclature (GMDN) Agency as partners.

The GMDN Agency is responsible for the Global Medical Device Nomenclature used for identification of medical devices. Formed in 1991, medical device experts from around the world (regulators, healthcare providers and manufacturers) have compiled the GMDN to facilitate taxonomy on medical devices.

GMDN is a list of generic names used to identify all medical device products including those used in the diagnosis, prevention, monitoring, treatment or alleviation of disease or injury in humans.

A standardized and unambiguous system for naming and coding medical devices is critical in an environment increasingly dependent on electronic data records for sharing and storing patient information. GMDN is recommended by the International Medical Device Regulators Forum (IMDRF) and is now used by over 70 national
medical device regulators to support their activity.

With AMTZ as a Consulting Organisation to GMDN, it will be a great value-addition to all the manufacturers at AMTZ. GMDN association with AMTZ will come as an enabler of export and global market expansion potential.

In order to facilitate regulation of medical device with classification system as stipulated in medical device rules, 2017 among other aspects like sale and distribution, import and labeling of medical devices, Union Health Ministry has permitted AMTZ to host a dedicated help desk for understanding and smooth implementation of Medical Device Rules, 2017.

The help desk would also facilitate information on following changes of medical devices rules to manufacturers like licensing authorities and functions of notified body, manufacture of medical devices for sale and distribution, import and labeling of medical devices, clinical investigation of medical device and clinical performance evaluation of IVD’s, import or manufacture medical device which does not have predicative device, duties of medical device officer, medical device testing officer and notified body, registration of laboratory for carrying out test for evaluation.

Taking forward its mandate of Make in India, Government of Andhra Pradesh last year established country’s first medical technology manufacturing park, AMTZ in Vishakhapatnam. N Chandrababu Naidu, chief minister of Andhra Pradesh laid the foundation stone of AMTZ.

Since then, AMTZ has received good response in terms of commencing of booking of plots and its active participation at Indian Medical Device Conference – 2017, one of the largest events for the Indian pharmaceutical market.

The Union health ministry notified the Medical Devices Rules, 2017 which will come into force from January 1, 2018.

These Rules will be applicable to substances used for in vitro diagnosis and surgical dressings, surgical bandages, surgical staples, surgical sutures, ligatures, blood and blood component collection bag with or without anticoagulant covered under sub-clause (i); substances including mechanical contraceptives (condoms, intrauterine devices, tubal rings), disinfectants and insecticides notified under sub-clause (ii); and devices notified from time to time under sub-clause (iv), of clause (b) of section 3 of the Drugs and Cosmetics Act, 1940 (23 of 1940).

AMTZ joins hands with GMDN Agency

Providing the much required boost to manufacturers of medical devices, Andhra Pradesh MedTech Zone (AMTZ), India’s first state-of-the-art medical devices manufacturing park, recently joined hands with GMDN Agency as a partner.

The move, which attracted attention of medical device fraternity across the world, is aimed at providing the much required boost to manufacturers of medical devices by promoting exports and facilitating global expansion.

GMDN, compiled by medical device experts from around the world, came into existence in 1991 to enable taxonomy on medical devices.

GMDN is a compilation of generic names to identify medical devices used in the diagnosis, prevention, monitoring, treatment or alleviation of disease or injury in humans.

AMTZ will collaborate with GMDN as a consulting organisation, bringing value-addition to the makers of medical devices in the 270-acre business park located in Visakhapatnam, which is dedicated to medical device manufacturing.

Taxonomy of medical devices assumes significance in view of the increasing importance of electronic data records for sharing and storing patient information.

The International Medical Device Regulators Forum (IMDRF), which was established in 2011 with an aim to harmonise medical device regulatory activities across the globe, recommends GMDN to regulators and is being used by over 70 national medical device regulators to support their activity.

AMTZ hails GST policy on medical devices

As India moved closer towards a country-wide Goods and Services Tax (GST) on Thursday with the GST Council fixing tax rates of 1,211 items, the Andhra Pradesh Medtech Zone (AMTZ) has hailed the new policy that is considered as the biggest tax reform since Independence aimed at improving ease of doing business in the country.

The GST Council broadly agreed on four tax brackets for services, which are 5 per cent, 12 per cent, the standard 18 per cent and the luxury rate of 28 per cent. It will subsume excise and service tax, and various other local levies including VAT and octroy.

“The rate of GST applicable on medical sector has been extremely encouraging,” said Dr Jitendar Sharma, CEO of AMTZ, which is India’s first ultra modern medical equipment manufacturing zone located in Visakhapatnam.

AMTZ being a harbinger of medical devices production in India, has been the flagship programme for medical devices sector and is set to boast of over 200 companies in a span of two years.

Given the current rate on medical devices, which is VAT plus service tax plus octroy (in some locations), the GST on most medical devices shall fall at 12 per cent bar which would be about 4-6 per cent lesser than current market rates of taxation.

While, industry would be encouraged by this to achieve lower costs of manufacturing, the advantages of cost reduction are likely to get passed on to consumers. AMTZ believes that GST will bring a new era for medical devices domestic manufacturing.

Highlights of GST rates of IVD/medical devices are as below:

Nil Human Blood Products, Condoms and Contraceptives, Hearing Aids etc.,
5% Nuclear Grade Chemicals, Human/Animal Blood vaccines, Human/Animal Blood vaccines, diagnostic test kits, Cardiac stents, artificial kidney, dialyzers, rehabilitation aids, Bio gas Plant, etc.
12% Anesthetics; animal blood prepared for therapeutic, prophylactic or diagnostic uses; Medicaments; ayurvedic; homeopathic; gauges, bandages, dressing, plasters used for medical, dental and veterinary purpose; sterile surgical sutures, absorbable surgical sutures, sterile tissue adhesives; photographic plates and film for X ray for medical use; surgical rubber gloves/ medical examination rubber gloves, nipples of feeding bottles; contact lenses; glucose meters; instruments, surgical, electromedical apparatus, respiration apparatus, breathing accessories, orthopedic appliances; X- ray apparatus of medical surgical dental use, X- ray generators, X- ray tubes and radiotherapy machines; LED Lights; drugs and medicines intended for personal use and etc,.
18% Radioactive chemical elements and radioactive isotopes (including the fissile or fertile chemical elements and isotopes) and their compounds, mixtures and residues containing these products; Diagnostic laboratory reagents; Glasses for corrective spectacles; screws, bolts, nuts, rivets and brain plates; nuclear reactors and isotope separators; steam/vapor boilers, steam and hydraulic turbines; industrial electric furnaces and ovens; laboratory equipment for heat treatment of materials; optical fibers; calibration apparatus for checking and measuring flow, level, pressure and gases; medical furniture’s, ORtables and other chairs and etc.
28% glass envelopes including tubes and bulbs, CRT Tube; autoclaves, tissue culture chambers; batteries, vacuum cleaners, shavers, hair clippers, electromechanical domestic appliances; optical microscopes; weight balances of 5 cg and etc.

3rd WHO Global Forum On Medical Devices, Geneva

Indian Medical Device sector gets a shot in the arm – next venue for this prestigious Global Summit will be New Delhi

More than 650 global medical device and healthcare representatives congregate at WHO headquarter to deliberate on ways to increase access to priority medical devices under the Universal Health Coverage in compliance with the Sustainable Development Goals and share evidence of best practices in regulation and management of devices.
12th May, 2017, Geneva: New Delhi will be the venue for the next WHO Global Forum on Medical Devices, the most prestigious and biggest global congregation on medical devices, reflecting the fast growing acceptance of India as an emerging global hub for medical device manufacturing and development. The decision to this regard has already been taken by the WHO Global Forum and it will be formally announced on Saturday, 13th May, 2017 at the closing of 3rd WHO Global Forum on Medical Devices.

More than 650 top global medical device representatives and healthcare experts congregated at the 3rd WHO Global Forum on Medical Devices at Geneva to deliberate on ways and means to increase access to priority medical devices under the Universal Health Coverage in compliance with the Sustainable Development Goals and share evidence of best practices in regulation and management of devices.

The global event was flagged off on 9th May 2017 by Dr Suzanne Hill, Director Essential Medicines and Health Products Department, WHO in the presence of dignitaries and industry representatives from across continents. Indian Medical Device Industry was represented by AiMeD led by Mr Rajiv Nath, Forum Coordinator of the Body.

The three day conclave has been deliberating on diverse topics related to medical device and healthcare delivery such as innovation acceleration to implementation of best regulatory practices, mobile health solutions, ICT in healthcare, education, training etc.

“The world is looking at India. We have the respect and the attention in building our ability to provide access to high quality affordable medical devices and the evolving ecosystem in India to enable manufacturing here more disciplined and competitive. I have attended all 3 conferences so far and India has the largest contingent ever of delegates and speakers flying the Indian Flag.” Said Mr Rajiv Nath, Forum Coordinator, AiMeD.

Dr Jitendra Sharma , CEO of AMTZ spoke about developing the country’s road map for Health Technology management based on better Service Delivery, coordinated and prioritised Technology Policy and tweaking the Trade Policy; Dr E Reddy the Jt Drug Controller gave a presentation on ongoing reforms on Medical Devices regulations in India, Dr Madhur Gupta from WHO India office presented the progress on the evolving landscape to manufacture medical devices in India and the ongoing reforms as Make in India enablers and there were others from NHSRC and product developers showcasing their cost effective innovation in home grown medical technology .

“The world is looking for cost effective high quality medical devices from India as an alternative global supplier. India has to work hard to become the global hub for medical devices and show other developing Countries what is needed to assist local production. Exciting times indeed – next steps is accelerating reforms of the other Make in India and Ease of Doing business enablers.”

“Also there was good learning from progress made by other countries like Saudi Arabia, Tanzania and ASEAN those who have already created the robust regulatory framework needed to protect their people and their economies.” Added Mr Rajiv Nath.

Health ministry approves AMTZ to host help desk for implementation of Medical Devices Rules, 2017

Shardul Nautiyal, Mumbai
Thursday, May 04, 2017, 08:00 Hrs [IST]
In order to facilitate regulation of medical device with classification system as stipulated in medical device rules, 2017 among other aspects like sale and distribution, import and labeling of medical devices, Joint Secretary of Ministry of Health and Family Welfare (MoHFW) K L Sharma has permitted AMTZ to host a dedicated help desk for understanding and smooth implementation of Medical Device Rules, 2017.

The help desk would also facilitate information on following changes of medical devices rules to manufacturers like licensing authorities and functions of notified body, manufacture of medical devices for sale and distribution, import and labeling of medical devices, clinical investigation of medical device and clinical performance evaluation of IVD’s, import or manufacture medical device which does not have predicative device, duties of medical device officer, medical device testing officer and notified body, registration of laboratory for carrying out test for evaluation.

The Union health ministry notified the Medical Devices Rules, 2017 which will come into force from January 1, 2018.

These Rules will be applicable to substances used for in vitro diagnosis and surgical dressings, surgical bandages, surgical staples, surgical sutures, ligatures, blood and blood component collection bag with or without anticoagulant covered under sub-clause (i); substances including mechanical contraceptives (condoms, intrauterine devices, tubal rings), disinfectants and insecticides notified under sub-clause (ii); and devices notified from time to time under sub-clause (iv), of clause (b) of section 3 of the Drugs and Cosmetics Act, 1940 (23 of 1940).

Taking forward its mandate of Make in India, Government of Andhra Pradesh last year established country’s first medical technology manufacturing park, Andhra Pradesh MedTech Zone (AMTZ) in Vishakhapatnam. N Chandrababu Naidu, chief minister of Andhra Pradesh laid the foundation stone of AMTZ.

Since then, AMTZ has received good response in terms of commencing of booking of plots and its active participation at Indian Medical Device Conference – 2017, one of the largest events for the Indian pharmaceutical market.

Dr Jitendar Sharma, director and chief executive officer of AMTZ, said, “I am extremely thankful to Government of India for making first help desk from AMTZ to support manufacturers in understanding of the new rules. This will go a long way in improving manufacturing potential.”

Proposed to be built on 271 acres of land with a seed capital of Rs. 25 crore, AMTZ will set up in-house high capital intensive common scientific facilities helping medical device manufacturers reduce the cost of manufacturing in the country.

The medical device park is proposed to have all such facilities in-house that are required for specialized product verticals to reduce manufacturing process costs. The park will provide modern state of art common facilities such as specialised laboratories, warehousing and a testing centre.

The AMTZ with in-house high investment scientific facilities would help manufacturers reduce the cost of manufacturing by more than 40 per cent to 50 per cent. Currently, due to lack of such centrally located shareable facilities, either manufacturers do not undertake production of technologies requiring them or send their products abroad for process up-gradation and value addition. While the zone would have all such facilities in-house to reduce manufacturing process costs, it would be located in an area which is well connected with railways, roadways, waterways and airways with near presence of industrial corridors, port and harbour to reduce logistical costs.

AMTZ releases report on medical device mfg in India in collaboration with WHO, DIPP, DoP

AMTZ releases report on medical device mfg in India in collaboration with WHO, DIPP, DoP

Shardul Nautiyal, Mumbai
Thursday, February 16, 2017, 08:00 Hrs [IST]
Andhra Pradesh MedTech Zone (AMTZ) in collaboration with Department of Pharmaceuticals (DoP), Department of Industrial Policy and Promotion (DIPP) and World Health Organization (WHO) has released a report titled “Medical Device Manufacturing in India: A Sunrise”.

AMTZ is India’s first government funded medical devices manufacturing park at Visakhapatnam in Andhra Pradesh. The foundation stone of India’s first exclusive medical device manufacturing park was laid on August 19, 2016 at Nadupur village of Pedda Gantyada Mandal in Vishakhapatnam by Andhra Pradesh chief minister Chandrababu Naidu.

The major aim of this report is to analyse the current situation and provide suggestions for the future developments in the medical device manufacturing area. The report emphasizes the need for collective measures from the government, industry and research community which will lead to reduction in healthcare costs across the country.

The report gives a low down on global and Indian medical device market highlighting global and Indian medical device market size, segments, growth factors for high demand in India, existing and proposed device clusters in the country, high import trend in Indian scenario and high potential manufacturing segments in India.

Other areas touched upon include improving regulatory landscape for medical devices in India. It focuses on the changes brought about in the regulatory scenario to boost the medical device manufacturing in India. The various initiatives include Materiovigilance Programme of India, Schedule M-III, mandatorily significant experience for manufacturing supervisor, Drugs & Cosmetic (Amendment) Bill, 2015, Draft National Medical Device Policy, 2015, Make in India initiative, establishment of medical device parks and medical device testing labs, corrections in the inverted duty structure, voluntary scheme for certification of medical devices – ICMED, WHO global model regulatory framework for medical devices including IVDs, July 2016.

The report also talks about situational analysis of core medical devices manufacturing sector. A situational analysis of medical devices core manufacturing sector (non-import) based on the survey conducted by AiMeD, PHD Chambers of Commerce and Industry and the World Association for Small and Medium Enterprises (WASME) is presented in the report.

The key findings in the report towards following actionable dimensions for the medical device industry are registration and certification, R&D and Intellectual Property, investments and turnover, human resources and skills and product range.

The report was released at India Medical Device Conference-2017 jointly organized by the DoP, DIPP and Federation of Indian Chambers of Commerce & Industry (FICCI) recently. India Medical Device Conference 2017 is one of the largest exhibition and conference for the Indian Pharmaceutical market.

Session was attended by Union Minister for Chemicals and Fertilizers Ananth Kumar, Chief Minister of Karnataka Siddharamaiah, Minister of State for Chemicals and Fertilizers Mansukh L Mandaviya, Nirmala Sitharaman, Minister of State for Commerce & Industry, Dr. Henk Bekedam, WHO Representative to India and officials from the government, industry and trade associations.

The swift work and progress done in a matter of 6 months from the time of inception of AMTZ was applauded by the audience and everybody present at the event.

AMTZ has already announced bookings of factories at a refundable fee of Rs.6,250; Rs.12,500 & Rs.25,000 for a 0.25 acre; 0.50 acre and 1.00 acre manufacturing unit respectively. AMTZ has been receiving bookings continuously since the launch of booking on 2nd October.

AMTZ would include facilities such as component testing centre, electro-magnetic interference laboratory, medical grade low vacuum molding, cabinet molding, injection molding centres, 3D designing and printing for medical grade products, sterilization and toxicity testing centre, radiation testing centre, gamma irradiation facility, rapid prototyping centre, warehousing and regulator’s office.

AMTZ applauded at India Medical Device Conference-2017

The Andhra Pradesh MedTech Zone (AMTZ) occupied the centre stage at the recently held India Medical Device Conference-2017, which was jointly organised by the Department of Pharmaceuticals, Department of Industrial Policy Promotion and Federation of Indian Chambers of Commerce & Industry (FICCI).

The India Medical Device Conference 2017 was one of the largest events for the Indian Pharmaceutical market. The inaugural session was attended by Ananth Kumar, Union Minister for Chemicals & Fertilisers; Siddharamaiah, Chief Minister of Karnataka; Mansukh L Mandaviya, Minister of State for Chemicals & Fertilizers; Nirmala Sitharaman, Minister of State for Commerce & Industry; Dr HenkBekedam, WHO Representative to India and a plethora of other guests from the government, industry and trade associations.

The inaugural session also witnessed medical devices being declared as a separate segment by Sitharaman followed by the release of the report titled “Medical Device Manufacturing in India: A Sunrise”, which is the first of it’s kind in India.

The report was prepared in joint collaboration between Andhra Pradesh MedTech Zone (AMTZ), DoP, DIPP and WHO. The swift work and progress done in a matter of six months from the time of inception at AMTZ was applauded by the Ministers and everybody present at the event.

With manufacturers from across the country and MNCs forming a beeline to be a part of AMTZ, the India Medical Device Conference 2017 & India Pharma 2017 emerged as a platform to show the world that AMTZ is a Make in India dream come true to reduce the cost of healthcare in the country and world over.

Govt’s decision to delink medtech from pharma to boost its growth

Bangalore: The big day for domestic medical device industry has finally arrived. In order to boost ‘Make in India’ program and reduce import dependency, government has decided to include back medical device sector as one of the 25 flagship industry to steer the program.

This was announced by Union Minister of state for Commerce Ms Nirmala Sitharaman at the inaugural session during the National Conference “Indian Pharma and India Medical Devices-2017” here.

“Like Pharma has earned respect worldwide, I hope medical devices similarly earn this respect globally and achieve global manufacturing competitiveness. Medical devices is now being made a part of 25 Make in India focus sectors,” said Ms Sitharaman at the conference amid the presence of senior representatives from Central an State government as well as top representatives from pharma and medical device sector.

There were other good news for the sector. The Government also announced the delinking of medical device from pharma sector so that it can chart a distinct and definitive course along with distinct and facilitating regulatory framework. The same was announced by the Union Minister for Chemicals and Fertilizer, Mr Ananth Kumar here at the conference.

“Time for this sector to fly like butterfly and the pharmaceutical and medical devices to be spun off as a separate ministry of pharmaceutical and medical devices. I have recommended this to the Honorable Prime Minister and this request is under active consideration by the PM and PMO,” said Mr Kumar.

Till now, the medical device sector has been governed by the “Drugs & Cosmetics Act, 1940” which was primarily meant for regulating the pharmaceutical industry and for pharma manufacturing purpose, the nodal industry has been Ministry of Chemicals & Fertilizer. Globally, the medical device industry is completely separate from pharma sector and governed by separate set of legislations and regulatory framework than pharam. The Indian medical device industry has for a very long time been urging that this inconsistency has been one of the chief bottlenecks for the growth of the industry and hampered its development as a globally competitive on the lines of Indian pharma sector. Currently India imports over 70% of its medical device requirements and the total annual market size is estimated at over USD 10 billion.

The government has also decided to bear the cost of effluent treatment plant and provide some basic facilities free of cost at the upcoming medical device parks in states such as Andhra Pradesh, Haryana, Gujarat and Maharashtra, to make it globally competitive. This move has the potential to bring down the cost of medical device manufacturing in India by as much as 30%.

Industry has wholeheartedly lauded the latest developments and the Government’s decision to boost domestic medical device.

“We are very happy to note that the honourable ministers (Mr Kumar and Ms Sitharaman) spoke about need of affordability, availability, acceptability and also the need for viability for the manufacturers to enable growth and competitiveness,” said Mr Rajiv Nath, Forum Coordinator, AiMeD. Mr Nath was part of the special invitees to the Conference and AiMeD has been striving and advocating for years to accord medical device to bring under separate regulatory framework so that it could realize its potential while India’s humungous import dependency comes down.

AiMeD has also recommended and submitted 6-point roadmap to the government for making India a true global powerhouse for medical devices. These include:

1: Tariff Rationalisation: Basic Import Tariff to be 10% for Medical Devices (whose Export is over 5 Crores) and Duty on Components to be 5% Next Year and 7.5% thereafter as a Make in India Enabler. Concessional Duty on Raw Material may be retained at 2.5% for now, for Next 3 Years.

2: Regulations for Patient Safety: Draft Proposed Regulatory Rules to be amended for :

i) Voluntary Compliance backed by 3rd Party ICMED Certification to be considered as a Compliance option.
ii) Cover High Risk Devices also in 3rd Party Certification as being done for Low Risk.
3: Buy Indian Policy of Preferential Market Access and Preferential Pricing (as per World Bank Terms) for Indian Medical Device for Indian Public Healthcare Tenders

4: Consumer Protection: MRP labelling to be enforced on Unit of Sale of Medical Devices. No NPPA for Medical Devices other than case of Stents (Combination Device, having Drug). Introduce Price Cap Mechanism of 4-5 times Ex-Factory / Import Landed Price in a Phased Manner or bring in a 1% Cess on Excise / GST on MRP to act as Disincentive for putting Exorbitant MRP and to incentivise ethically correct Low MRP.

5: Ban on Refurbished Medical Equipment, for Next 5 Years till such time we have a strong Regulatory Regime to ensure validated and calibrated Equipments limited access, for enabling Patient Safety.

6: Medical Device Export Promotion & Import Substitution Council – It can be called by any Name, but to focus on these aspects, to address India’s 70% Import Dependency, 90% on Medical Electronics.

Good response to India’s first medical devices making park

Government developing it in 270 acres at Nadupuru in Pedagantyada mandal

VISAKHAPATNAM: The Andhra Pradesh MedTech Zone Limited, a special purpose vehicle floated to set up India’s first medical devices manufacturing park in Visakhapatnam, is buoyed by the response to investment in the proposed facility.

“We are getting bookings continuously ever since we opened it to the investors on October 2, 2016,” a senior official of the SPV told The Hindu on Thursday. The park, which is being made a reality by its CEO Jitendra Sharma, is the brainchild of Chief Minister N. Chandrababu Naidu, who had laid the stone for the ambitious project a few months ago.

The State Government is developing the park in 270 acres at Nadupuru village in Pedagantyada mandal. It is in close proximity to Ukkunagaram township of the Visakhapatnam Steel Plant.

Huge market

The response at the investors’ meet held by the zone in Dusseldorf in Germany recently had evoked an overwhelming response, mainly due to the huge size of the market in India. The zone is planning to hold a series of investors’ meets both in India and abroad.

Booking for units has been sought at a concessional rate for allotment of land in quarter, half and one acre. The zone will have all facilities under one roof, including electromagnetic interference, low vacuum, toxicity, radiation, and rapid photo-typing testing laboratories.

In a shot in the arm, the zone recently signed MoU with the Quality Council of India for adhering to global benchmarking in the manufacture of medical devices.

The State Government is envisaging an investment by 200-300 units in the park with an estimated investment of ₹30,000 crore to create job opportunities for at least 25,000 people.

As part of the ‘Make in India’ programme, the importance given to encourage medical devices within the country in the general budget for 2017-18 would go a long way in reducing the cost of healthcare,” said V. Muralikrishna, managing director of Mahatma Gandhi Cancer Hospital and Research Centre.

Most of the devices required for diagnostics are now sourced either from Europe, America, or China.

“Hence, making medical devices will not only help save foreign exchange but also create job opportunities,” he said, and sought preference to local entrepreneurs who had already invested in healthcare for collaborating with foreign investors.

Govt notifies Medical Devices rules, 2017

New Delhi: Union health ministry on Thursday notified Medical Devices Rules, 2017 that separates regulatory norms for manufacturing medical devices from drugs.

The notification has come a day after finance minister Arun Jaitley mentioned during the Union Budget about forming new rules for regulating medical devices in the country to ease norms for manufacturing medical devices in the country and to promote domestic industry.

The medical devices could range from simple devices such as thermometers and disposable gloves to x-ray, CT, MRI machines and implantable devices such as stents and artificial joints.

The new rules have eased norms for obtaining license and conducting clinical trials, and also reduced manufacturer-regulator interface by promoting digital platform.

The government has heeded to the industry’s nearly decade-long demand of separating it from pharmaceutical industry so that the same stringent laws that regulate drugs are not applicable to medical devices.

“Till now medical devices were regulated as drugs but now we have separated the two and formed rules specifically catering to the medical devices industry,” KL Sharma, joint secretary, health ministry told HT.

Medical devices have been divided in four categories based on their risk type— Class A, B, C and D, where A&B are low risk devices such as x-ray, CT, MRI etc. and C&D have higher risk quotient such as stents and other implantable devices. For approvals and licensing in devices falling under category C & D, central government will be directly involved.

The industry will no longer have to follow stringent clinical trial guidelines spanning four phases, like in case of drug trials.

The rules are aimed to standardise and regulate medical devices manufacturing industry, on par with international standards. The new Rules have been framed in conformity with Global Harmonisation Task Force (GHTF) framework and follow best international practices.

The move will boost government’s ‘Make in India’ campaign by providing conducive environment for domestic manufacturers that could lead to greater long-term investments.

Clinical trials norms have been relaxed.

“For medical devices it will be called clinical investigations that won’t require trials running up to four phases. Only a pilot study on smaller population to test safety and performance of the device and later a trial on pivotal basis on a larger population,” said Sharma.

The rules have a provision for awarding compensation up to ₹8 lakh to people impacted by trials adversely.

“This rule has been introduced for the first time in the world. We will also be appointing an accredited outside agency to do the audit of the manufacturing units, which is also a first.”

The rules will come into effect from January 1, 2018. “We have given them a year to prepare for the necessary change and ensure compliance,” said Sharma.

AMTZ inks MoU with QCI for ICMED certification

AMTZ inks MoU with QCI for ICMED certification
Shardul Nautiyal, Mumbai
Tuesday, January 24, 2017, 08:00 Hrs [IST]

As a step towards protecting industry from faulty medical devices and reliance on international certifications, Andhra Pradesh MedTech Zone (AMTZ) recently signed an MoU with the Quality Council of India (QCI) to promote Indian Certification for Medical Devices (ICMED) Scheme in India.

Developed in collaboration with AiMeD, QCI and the NABCB – ICMED is a quality certification scheme for medical devices in the country with an aim to enhance patient safety, and increase consumer protection along with providing much needed product credentials to manufacturers to instil confidence among buyers.

The scheme is also intended to significantly eliminate trading of sub-standard products or devices where supply chains are unknown, a widespread and injurious occurrence in the Indian market.

The MoU was signed by Dr. Jitendar Sharma, chief executive officer, AMTZ and Dr. R. P. Singh, secretary general, QCI in the presence of Dr. Kamineni Srinivas, Health and Medical Education Minister, Government of Andhra Pradesh; Dr. Poonam Malakondaiah, principal secretary, Health Medical & Family Welfare, Government of Andhra Pradesh; Rajiv Nath, forum coordinator, Association of Indian Medical Device Industry (AiMeD); Anil Jauhri, chief executive officer, National Accreditation Board for Certification Bodies (NABCB); and Mrutunjay Jena, joint director, NABCB and other distinguished guests.

Currently, with no established mandatory quality certifications for medical device manufacturing sector in India, the medical devices manufactured in India lack an element of competitiveness with respect to the imported medical devices.

With manufacturers forming a bee-line to start manufacturing at AMTZ, this collaboration with QCI would help the manufacturers be ICMED compliant from the first day itself.

AMTZ and QCI would be working closely in this direction by joint selection of agencies for empanelment for promotion of quality in medical devices and even facilitating manufacturing of identified technologies at AMTZ.

AMTZ which is India’s first medical devices manufacturing park has already announced bookings of factories at a refundable fee of Rs.6,250; Rs.12,500 & Rs.25,000 for a 0.25 acre; 0.50 acre and 1.00 acre manufacturing unit respectively. AMTZ has been receiving bookings continuously since the launch of booking on 2nd October.

Government of Andhra Pradesh and senior management of Andhra Med Tech Zone had also led an ‘exclusive investors meet’ at world’s largest and most attended medical devices expo -Medica on November 15, 2016 at Dusseldorf, Germany. This was AMTZ first international summit at Dusseldorf.

Dr. Jitendar Sharma said that the response from industry has been very encouraging and 10 per cent of the proposed factories have already been booked since October 2, 2016 when the booking for AMTZ was launched. The zone has received applications from some of the largest companies.

AMTZ would include facilities such as component testing centre, electro-magnetic interference laboratory, medical grade low vacuum molding, cabinet molding, injection molding centres, 3D designing and printing for medical grade products, sterilization and toxicity testing centre, radiation testing centre, gamma irradiation facility, rapid prototyping centre, warehousing and regulator’s office.

AMTZ signs MoU with QCI for quality certification

The Andhra Pradesh MedTech Zone (AMTZ), India’s first ultra modern medical equipment manufacturing zone in Visakhapatnam, has signed a Memorandom of Understanding (MoU) with the Quality Council of India (QCI) for the promotion of Indian Certification for Medical Devices (ICMED) Scheme in India in order to significantly eliminate trading of sub-standard products or devices where supply chains are unknown.

The MoU was signed by Dr Jitendar Sharma, CEO, AMTZ and Dr RP Singh, Secretary General, QCI in the presence of Andhra Pradesh Health and Medical Education Minister Dr Kamineni Srinivas and Principal Secretary Health Medical and Family Welfare Dr Poonam Malakondaiah.

Among other distinguished guests at the MoU signing ceremony were Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry (AiMeD), Anil Jauhri, CEO, National Accreditation Board for Certification Bodies (NABCB) and Mrutunjay Jena, Joint Director, NABCB.

Developed in collaboration with AiMeD, QCI and NABCB – ICMED is a quality certification scheme for medical devices in the country with an aim to enhance patient safety, and increase consumer protection along with providing much needed product credentials to manufacturers to instill confidence among buyers.

Currently, with no established mandatory quality certifications for medical device manufacturing sector in India, the medical devices makers in the country lack an element of competitiveness with respect to the imported medical devices.

PHD Chamber in association with AMTZ organise seminar

The seminar threw up opportunities for foreign collaborations for technology transfers and financing for setting up units

PHD Chamber in association with AMTZ (Andhra MedTech Zone) recently organised a seminar on ‘Medical Electronics International collaborations & Financing for Manufacturing’ in Jaipur.

AMTZ aims to make India a self-sufficient and in fact an exporter of good quality and cost-effective medical technology. The objective of the seminar was to familiarise the industry on this opportunity which exists in fulfilling the gap which is only likely to widen as healthcare services reach out to semi-urban and rural areas. The seminar also threw up opportunities for foreign collaborations for technology transfers and financing for setting up units.

ML Gupta, Co Chairman of Rajasthan Committee, PHD Chamber addressed the delegates and briefly informed them about AMTZ.

The conference was presided over by Nitin Bharadwaj, Vice-President (HR and Administration), AMTZ. He talked about the benefits of being the part of AMTZ project at Visakhapatnam, where they are offering plug-n-play infrastructure, lower cost testing services, lower capex for manufacturers, regulators and export facilitation, promotional activities through EXPO/ convention centre, finance and technology transfer services, preferential market access Circa and all other facilities commonly required in the manufacturing of medical devices etc.

Vikas Varma, Financial Advisor and Internal Auditor, AMTZ, shared AMTZ’s value proposition for investors. He talked about multiple fiscal incentives provided by AMTZ to companies participating in the project.

Nagaraju Devarajugattu, SM Operations, AMTZ, informed the delegates on the plot booking procedure with specifics on investment in AMTZ. He also gave a live demo on the plot booking procedure for better understanding.

Vivek Seigell, Director, PHD Chamber, appreciated the efforts being taken by Government of Andhra Pradesh and urged industry members to come upfront and be a part of the AMTZ project.

AMTZ to host International Fellowship programme on HTA at Vishakhapatnam

AMTZ to host International Fellowship programme on HTA at Vishakhapatnam
Our Bureau, Mumbai, Saturday, December 17, 2016, 08:00 Hrs [IST]

For better understanding of Health Technology Assessment (HTA) among manufacturers and innovators, an International Fellowship programme on Health Technology Assessment is going to be conducted in Andhra Pradesh Med Tech Zone (AMTZ) at Vishakhapatnam, between January 9, 2017 and January 13, 2017.

HTA is a multi-disciplinary field that examines the clinical, economic, social and ethical implications of medical technologies. It refers to the process of using existing evidence to evaluate the clinical effectiveness, cost-effectiveness and broader impact of a health technology on patients and the healthcare system.

HTA is an internationally active field and has seen continued growth. It has also been advanced by the evolution of methods including clinical epidemiology and health economics and acts as a bridge between the world of research and decision-making process.

The five day Fellowship on Health Technology Assessment is 7th in series. The program will offer sessions by expert faculty in the subject of Systematic Reviews, Economic Analysis and Medical Technology Evaluation. The fellowship is useful for hospitals/healthcare program managers, innovators, professionals and providers in healthcare, health economists, students pursuing public health management and health biomedical and clinical engineers.

HTA is required for selection of interventions that improve healthcare delivery, conceptualization, recommendations and selection of health technologies, harm benefit assessment through an integrated patient safety approach and developing economic models by understanding basics of health economics.

Faculties include Prof Prakesh Shah, Professor, Department of Pediatrics and HPME, University of Toronto, Dr Anirban Basu, Director, Pharmaceutical Outcomes Research and Policy Program, University of Washington, Dr Jitendar Sharma, CEO, AMTZ and Program Director- HTA Fellowship, Dr Roli Mathur, Indian Council of Medical Research, New Delhi and Akriti Tomar, Consultant and Trainer, Health Technology Assessment (HTA)

Innovation and the actual needs of the health-care system should be linked more closely. Innovative products that provide the most value for investment must be identified and their manufacturers should be supported with appropriate and high investment facilities that could reduce the cost manufacturing. They should also be support with evidence based and outcome centric knowledge on products and technologies.

AMTZ is India’s first ultra modern medical equipment manufacturing zone with state of art 250+ manufacturing units along with scientific laboratories critical to medical technology production. The goal of this progressive initiative would be to encourage medical technology innovators scale new heights by providing them with appropriate and strategic avenues with an aim to improve access to healthcare. The details of fellowship is available on www.amtz.in

AMTZ to host international fellowship on health technology assessment

To develop better understanding of Health Technology Assessment (HTA) among manufacturers and innovators, an international fellowship on HTA will be conducted in Andhra Pradesh Med Tech Zone (AMTZ), Vishakhapatnam, from January 9-13 next year, an AMTZ statement said.

Health Technology Assessment refers to the process of using existing evidence to evaluate the clinical effectiveness, cost-effectiveness and broader impact of a health technology on patients and the healthcare system.

The AMTZ has called for paper presentation. “Authors are invited to submit abstracts of their HTA, which are original and unpublished. The selection will be based on merit and the last date to submit the abstract is 1st December 2016.”

The notification date of acceptance of abstract is 30th December 2016.

Innovation and the actual needs of the healthcare system should be linked more closely. Innovative products that provide the most value for investment must be identified and their manufacturers
should be supported with appropriate and high investment facilities that could reduce the cost manufacturing. They should also be support with evidence based and outcome centric knowledge on
products and technologies, according to AMTZ.

AMTZ is India’s first ultra modern medical equipment manufacturing zone with state of art 250 plus manufacturing units along with scientific laboratories critical to medical technology production.

The goal of this progressive initiative would be to encourage medical technology innovators scale new heights by providing them with appropriate and strategic avenues with an aim to improve access to
healthcare.

Chinese delegation visits AMTZ, explores investment opportunities

A Chinese delegation with over 30 investors recently visited Andhra Pradesh MedTech Zone (AMTZ) Ltd — India’s first 270-acre state-of-the-art medical devices manufacturing park with single window processing, common precision manufacturing facilities, reliable grid power and water availability, set in a scenic location of Visakhapatnam.

The delegation was led by Jessie Wei, Co-founder of SKK-JW Associates, and was facilitated by Surinder Kalra, Co-Chairman, Foreign Trade and Investment Committee, PHD Chamber of Commerce and Industry.

The three hours’interactive session on December 9 had the Chinese delegates discuss about various investment opportunities with AMTZ senior management led by Dr Jitendar Sharma, Director and CEO, AMTZ.

The delegation was familiarised with the various scientific facilities available at AMTZ. The background work and support available for the medical devices manufacturers impressed the delegates who were astounded by the AMTZ package.

One important feature which attracted the attention of the delegates was the presence of empanelled partners for technology transfer, human capital management and financial support.

The delegation was impressed upon with the various benefits of starting the manufacturing units at AMTZ. Appreciating the noble intentions of AMTZ, a delegation member aptly pointed out that “the speed and noble intention with which AMTZ is focused and moving ahead, it is bound to greater success bringing benefit to the global economy”.

AMTZ has already announced bookings of factories at a refundable fee of Rs 6,250, Rs 12,500 and Rs 25,000 for a 0.25 acre, 0.50 acre and 1 acre manufacturing unit, respectively. AMTZ has been receiving bookings continuously since the launch of booking on October 2.

China has shown interest in Andrhra Medtech Zone project -CHINESE DELEGATION & INVESTORS attended SUMMIT AT AMTZ

• A Chinese delegation of over 30 investors visited Andhra Pradesh MedTech Zone (AMTZ) Ltd. on December 09, 2016. The delegation was led by Ms.Jessie Wei(Co-founder of SKK-JW Associates) and was facilitated by Mr. SurinderKalra (Co-Chairman, Foreign Trade & Investment Committee, PHD Chamber of Commerce & Industry). The three hours’interactive session had the Chinese delegates discuss about various investment opportunities with AMTZ senior management led by Director & CEO, AMTZ – Dr.Jitendar Sharma. The delegation was familiarised with the various scientific facilities available at AMTZ. The background work and support available for the medical devices manufacturers impressed the delegates who were astouned by the AMTZ package.
– One important feature which attracted the attention of the delegates was the presence of empanelled partners for technology transfer, human capital management and financial support. The delegation was impressed upon with the various benefits of starting the manufacturing units at AMTZ. Appreciating the noble intentions of AMTZ, a delegation member aptly pointed out that “the speed and noble intention with which AMTZ is focused and moving ahead, it is bound to greater success bringing benefit to the global economy.”

• AMTZ – India’s first medical devices manufacturing park – has already announced bookings of factories at a refundable fee of Rs. 6,250; Rs. 12,500 &Rs. 25,000 for a 0.25 acre; 0.50 acre and 1.00 acre manufacturing unit respectively. AMTZ has been receiving bookings continuously since the launch of booking on 2nd October.

Chinese delegation discusses investment opportunities with AMTZ

Chinese delegation discusses investment opportunities with AMTZ
Shardul Nautiyal, Mumbai
Tuesday, December 13, 2016, 08:00 Hrs [IST]

Facilitated by co-chairman, Foreign Trade and Investment Committee, PHD Chamber of Commerce and Industry Surinder Kalra, a Chinese delegation of over 30 investors visited Andhra Pradesh MedTech Zone (AMTZ) Ltd recently to discuss investment opportunities.

The three hours’ interactive session had the Chinese delegates discuss about various investment opportunities with AMTZ. Senior management led by Director AMTZ Dr Jitendar Sharma and the Chinese delegation led by Co-founder of SKK – JW Associates Jessie Wei discussed about the work and support available for the medical devices manufacturers at AMTZ apart from familiarising delegates about the various scientific facilities available at AMTZ.

AMTZ which is India’s first medical devices manufacturing park has already announced bookings of factories at a refundable fee of Rs. 6,250; Rs. 12,500 & Rs. 25,000 for a 0.25 acre; 0.50 acre and 1.00 acre manufacturing unit respectively. AMTZ has been receiving bookings continuously since the launch of booking on 2nd October.

One important feature which attracted the attention of delegates was the presence of empaneled partners for technology transfer, human capital management and financial support.

The delegation was impressed upon with various benefits of starting the manufacturing units at AMTZ. Appreciating the noble intentions of AMTZ, a delegation member aptly pointed out that “the speed and noble intention with which AMTZ is focused and moving ahead, it is bound to greater success bringing benefit to the global economy.”

Government of Andhra Pradesh and senior management of Andhra Med Tech Zone also led an ‘exclusive investors meet’ at world’s largest and most attended medical devices expo -Medica on November 15 at Dusseldorf, Germany. This was AMTZ first international summit at Dusseldorf.

Medica summit saw tremendous support from Indian Trade Promotion Organization (ITPO) and Association of Indian Medical Device Manufacturers (AIMED) also. Since the foundation ceremony of AMTZ done by Andhra Pradesh Chief Minister Chandrababu Naidu on August 19, 2016, the AMTZ park has seen a steady stream of manufacturers.

Advisor to government of Andhra Pradesh and CEO of AMTZ Dr. Jitendar Sharma said that the response from industry has been very encouraging and 10 per cent of the proposed factories have already been booked since October 2, 2016 when the booking for AMTZ was launched. The zone has received applications from some of the largest companies.

AMTZ would include facilities such as component testing centre, electro-magnetic interference laboratory, medical grade low vacuum molding, cabinet molding, injection molding centres, 3D designing and printing for medical grade products, sterilization & toxicity testing centre, radiation testing centre, gamma irradiation facility, rapid prototyping centre, warehousing and regulator’s office.

Andhra Pradesh MedTech Zone Ltd

Dr Jitendar Sharma
Director & CEO
Organisation Details
Year of Inception: 2016
Management Team:
1. Judish Raj – VP (Planning)
2. Manish Gangal – VP (Operations)
3. Nitin Bharadwaj – VP (HR & Administration)
4. Vipin Ramachandran – VP (Finance)

Number of Employees: 50 to 100

Head Office:
Address Corporate Office:
Andhra Pradesh MedTech Zone,
Hill No. 2, IT Park, VSEZ, Madhurwada,
Visakhapatnam – 530045

Address Site:
Andhra Pradesh MedTech Zone,
S. No. 480/P, 187/P, 176/P, Nadupuru
Visakhapatnam – 530044

Website: www.amtz.in
Tel. No.: +91-8885092122
E-mail: info@amtz.in
Contact Person for Clarification: Sohan Dutta
Email: sohan.dutta@amtz.in
Contact No.: +91-8885092122
Target Verticals: Medical Devices & Equipment

Business Collaborations:
Association of Indian Medical Device Industry (AiMeD)
World Association for Small and Medium Enterprises (WASME)
Federation of Indian Chambers of Commerce & Industry (FICCI)
Andhra Chamber of Commerce
PHD Chamber of Commerce
BIORx Venture Advisors Pvt. Ltd.
MarksMan Healthcare Solutions
Monster.com
HDFC Bank

About

The creation of Andhra Pradesh MedTech Zone (AMTZ) is based on the fact that medical devices manufacturing requires certain high investment facilities which are too capital intensive for individual manufactures to invest upon. With a market size of close to $4 billion, 78% of the medical devices in India are imported from other countries. A park with in-house high investment scientific facilities would help manufacturers reduce the cost of manufacturing. While the park would have all such facilities in-house to reduce manufacturing process costs, it would have modern state of art 250-300 independent manufacturing units, each over a builtin ready to use area in 1.00 acres/0.50 acres/0.25acres at a very cost effective long term lease rate for 33 years. Located in an area which is well connected with Railways, Roadways, Waterways and Airways, with presence of Industrial Corridors, Port and Harbour to reduce logistical costs, AMTZ in Visakhapatnam is India’s first medical device manufacturing zone spread over 270 acres.

Products & Services

Pre-built Manufacturing Units with Plot Size of 0.25 acre, 0.50 acre and 1.00 acre
Common Scientific & Social Facilities
Component Testing & Board Manufacturing Centre
Electro-Magnetic Interference Laboratory
Biomaterial Testing Laboratory
Gamma Irradiation Centre
Medical Grade Low Vacuum Molding, Cabinet Molding, Injection Molding Centres
3 D Designing and Printing for Medical Grade Products
Sterilisation & Toxicity Testing Centre
Radiation Testing Centre
Centre for Medical Technology Innovations & Rapid Prototyping
Regulator’s Office
Empaneled Agencies to provide Technology Transfer & Financial Support
Showrooms & Offices
Med Tech Expo Hall
Convention Hall
Central Warehousing
USP

One stop solution for Medical Device manufacturers/innovators
Prebuilt manufacturing units
Capital Intensive common scientific facilities on pay per use model
Lower cost for Testing services
Lower Capex for manufacturers
Finance and Technology Transfer Services
Central Warehouse & Logistical Connectivity providing operational efficiencies
Promotional activities through Med tech Expo Halls, Convention Centre, etc.
Favourable Tax structure and policy revisions
Regulators and Export Facilitation
Preferential Market Access

AP govt, AMTZ hold first Investors’ meet at Medica, Germany; gets good response from industry

AP govt, AMTZ hold first Investors’ meet at Medica, Germany; gets good response from industry
Shardul Nautiyal, Mumbai

Friday, November 18, 2016, 08:00 Hrs [IST]
Government of Andhra Pradesh and senior management of Andhra Med Tech Zone (AMTZ) led an ‘exclusive investors meet’ at world’s largest and most attended medical devices expo -Medica on November 15 at Dusseldorf, Germany. This was AMTZ first international summit at Dusseldorf.

Advisor to government of Andhra Pradesh and CEO of AMTZ Dr. Jitendar Sharma said that the response from industry has been very encouraging and 10 per cent of the proposed factories have already been booked since October 2, 2016 when the booking for AMTZ was launched. The zone has received applications from some of the largest companies. Medica summit saw tremendous support from Indian Trade Promotion Organization (ITPO) and Association of Indian Medical Device Manufacturers (AIMED) also. Since the foundation ceremony of AMTZ done by CM Chandrababu Naidu on August 19, 2016, the AMTZ park has seen a steady stream of manufacturers.

As a step towards initiating the process for involving and inviting potential investors for the medical device park, bookings started from October 2, 2016 followed with short-listing eligible investors based on a selection criteria subsequent to the booking process.

Earlier, over 50 companies had shown interest and 38 companies submitted Expression of Interest (EoI) letters subsequent to Andhra Pradesh government inviting EoI letters from potential investors.

Proposed to be built on 271 acres of land with a seed capital of Rs. 25 crore, AMTZ will set up in-house high capital intensive common scientific facilities helping medical device manufacturers reduce the cost of manufacturing in the country.

The park will provide for all capital intensive scientific facilities required by most medical device manufacturers and modern state of art 180-200 independent manufacturing units, with varying sizes of 0.25 acre, 0.5 acre and 1 acre. AMTZ would include facilities such as Component testing centre, Electro-magnetic interference laboratory, Medical grade low vacuum molding, cabinet molding, injection molding centres, 3D designing and printing for medical grade products, Sterilization & Toxicity testing centre, Radiation testing centre, Gamma Irradiation facility, Rapid Prototyping Centre, Warehousing and Regulator’s office.

The Summit was attended by a large number of companies- both national and international. After an interactive session, the AMTZ project was applauded by the med tech industry as the first of the kind medical devices park.

The delegation had principal secretary Dr. Poonam Malakondaiah, AMTZ CEO Dr. Jitendar Sharma, vice-presidents – Judish Raj and Manish Gangal from Andhra Med Tech Zone. The summit also had participation from vice-counsel from Consulate General of India, at Germany TS Ramesh and officials of ITPO.

AMTZ woos investors at a meet in Germany

VISAKHAPATNAM: Senior officials of the AP government and AP Med Tech Zone (AMTZ) organised an investors meet at Medica, one of the world’s leading trade fairs for medical industry, at Dusseldorf in Germany, earlier this week.
According to AMTZ officials, a large number of companies from India as well as from other countries took part in the investors meet. The AP delegation led by principal health secretary Poonam Malakondaiah and AMTZ CEO Jitendar Sharma briefed investors about the proposed medical devices manufacturing facility in Vizag. AMTZ officials said it would provide capital intensive scientific facilities required by most medical device manufacturers and 180-200 modern independent manufacturing units of various sizes ranging from 0.25 acre, 0.5 acre and 1 acre.
AMTZ would also include facilities such as component testing centre, electro-magnetic interference laboratory, medical grade low vacuum molding, cabinet melting, 3D designing and printing for medical grade products among others.
AMTZ CEO Jitendar Sarma said the response from the industry has been encouraging and added that 10 per cent of the proposed factories have already been booked since October 2, when the bids started. He said AMTZ has received applications from some of the largest companies involved in medical devices manufacturing.
Stay updated on the go with Times of India News App. Click here to download it for your device.

To promote AMTZ, Andhra Pradesh holds investors meet in Germany

Eyeing international investors for the ambitious Andhra Pradesh MedTech Zone (AMTZ), a team consisting of state government officials and senior management of AMTZ led an “exclusive investors meet” on November 15 at Medica, the world’s largest and most attended medical devices expo that is being held in Dusseldorf, Germany.

The meet was attended by a large number of companies — both national and international. After an interactive session, the AMTZ project was applauded by the med tech industry as the first-of-its-kind business park dedicated to medical devices.

Following the foundation-laying ceremony of AMTZ by Chief Minister Chandrababu Naidu on August 19, 2016, the park has seen a steady stream of manufacturers. The zone held its first international summit at Dusseldorf.

The Andhra Pradesh delegation has Principal Secretary Dr Poonam Malakondaiah, AMTZ CEO Dr Jitendar Sharma, Vice-Presidents Judish Raj and Manish Gangal from Andhra Med Tech Zone. Vice Counsel from Consulate General of India at Germany, T S Ramesh, and officials of the Indian Trade Promotion Organisation (ITPO) also participated in the summit.

Speaking to media, Advisor to the Government of Andhra Pradesh and CEO of AMTZ Dr. Sharma said the response from industry had been very encouraging and 10 per cent of the proposed factories have already been booked since October 2 when the booking was opened. The zone has received applications from some of the largest companies in the world.

The park will provide for all capital intensive scientific facilities required by most medical device manufacturers and state-of-the-art 180-200 independent manufacturing units, with varying sizes of 0.25 acre, 0.5 acre and one acre.

AMTZ would offer facilities like component testing centre, electro-magnetic interference laboratory, medical grade low vacuum molding, cabinet molding, injection molding centres, 3D designing and printing for medical grade products, sterilisation and toxicity testing centre, radiation testing centre, gamma irradiation facility, papid prototyping centre, warehousing and regulator’s office.

AMTZ international summit held at Medica, Germany

Dusseldorf, Germany: Govt. of Andhra Pradesh officails and the senior management led an “exclusive investors meet” at Medica on 15th Nov at Dusseldorf, Germany. Medica is world’s largest and most attended medical devices expo.
Since the foundation ceremony of AMTZ done by CM Chandrababu Naidu on 19th August 2016, the park has seen a steady stream of manufacturers. The zone held its first international summit at Dusseldorf where the AMTZ delegation is participating. The delegation has Principal Secretary Dr. Poonam Malakondaiah, AMTZ CEO Dr. Jitendar Sharma, Vice-Presidents – Judish Raj and Manish Gangal from Andhra Med Tech Zone. The summit also had participation from Vice-Counsel from Consulate General of India, at Germany- Mr TS Ramesh and officials of Indian Trade Promotion Organization(ITPO).
The Summit was attended by a large number of companies- both national and international. After an interactive session, the AMTZ project was applauded by the med tech industry as the first of the kind medical devices park. The park will provide for all capital intensive scientific facilities required by most medical device manufacturers and modern state of art 180-200 independent manufacturing units, with varying sizes of 0.25 acre,0.5 acre and 1 acre. AMTZ would include facilities such as Component Testing centre, Electro-magnetic interference laboratory, Medical grade low vacuum molding, cabinet molding, injection molding centres, 3 D designing and printing for medical grade products, Sterilization & Toxicity testing centre, Radiation testing centre, Gamma Irradiation facility, Rapid Prototyping Centre, Warehousing and Regulator’s office.
Speaking to media, Advisor to Govt. of AP and CEO of AMTZ Dr. Sharma said that the response from Industry has been very encouraging and 10% of the proposed factories have already been booked since 2nd Oct when the booking was launched. The zone has received applications from some of the largest companies. Medica Press covered the summit which saw tredemdous support from Indian Trade Promotion Organziation (ITPO) and Association of Indian Medical Device Manufacturers (AIMED).

AMTZ empanels employment portal

VISAKHAPATNAM: The Andhra Pradesh Med Tech Zone (AMTZ) has empanelled employment portal Monster.com as a talent search engine to benefit manufacturers who set up factories at AMTZ that is being developed at Nadupuru village. Booking of factories that commenced on October 2 has seen rapid applications from market leaders, said a release, added that skilled human capital is a major requirement for medical device manufacturers and talent search remains challenging. Solving the critical issue, AMTZ invited applications from major job search engines following which Monster.com was selected.

Swiss Innovation Park to come up in Visakhapatnam

Visakhapatnam: An innovation park on the lines of Swiss Innovation Park will come up in Vizag. In a boost to medical devices manufacturing park coming up at Vizag, Switzerland-based venture capital firm Med Tech Innovation Partners (MTIP) has agreed to set up the innovation park in the city.

The MoU in this regard will be signed by Chief Minister N. Chandrababu Naidu with the MTIP representatives during the upcoming World Economic Forum Summit in Davos.

MTIP has been instrumental in building the renowned Swiss Innova-tion Park, an independent catalyst for innovation in biotech and biomedical engineering, sciences, and technologies.

Foundation stone for a medical devices manufacturing park in a sprawling 200 acres near Anakapalle had already been laid. MTIP’s innovation park helps design new generation medical and health care devices.

Mr Naidu set foundation stone for South Asia’s first dedicated medical devices manufacturing park at Nadupuru village in the district in August. Vizag’s manufacturing park is called AP Med Tech Zone (AMTZ).

Over 50 companies have already shown interest and 38 have submitted Expression of Interest (EOI) letters. AMTZ, a company under Government of Andhra Pradesh, which has also received approval for funding on June 1, 2016 from the state Cabinet will implement the project of setting up the park.

There will be in-house high capital-intensive common scientific facilities helping medical device manufacturers to reduce the cost of manufacturing in the country. AMTZ will provide modern state-of-art common facilities such as specialised laboratories, warehousing, testing centre apart from 100 to 150 independent manufacturing units, each in a built-in ready to use area of 0.5 to 1 acre each.

“MTIP will create required eco system for innovation in medical devices manufacturing which will aid the prospects of AMTZ. This is a big boost to the medical manufacturing industry in Vizag,” said a senior district official.

Andhra Pradesh Economic Development Board (APEDB) CEO, J Krishna Kishore recently met key players of MTIP and discussed possibilities for creating a global ecosystem for Medtech innovations in Andhra Pradesh. MTIP has been instrumental in building the renowned Swiss innovation Park.

Use of refurbished medical equipment may lead to dumping of e-waste: Experts

VISAKHAPATNAM: Even as medical devices manufacturing is expected to take off in the next one year, industry sources said refurbished medical equipment may act as a counter initiative and could be a way to dump e-waste into the country by providing a cover of affordability. According to sources in the medical devices manufacturing sector, refurbished medical equipment could drain the country’s manufacturing capacities without benefitting patients.
No patient gets a cheaper care just because of being scanned or treated on a refurbished machine, according to the industry sources, who also mentioned that while entry of third-rate refurbished equipment benefit hospitals to maximise revenues with lower capital, patients are subjected to risky procedures on old machines and charged humongous fees.
For the OEM (Original Equipment Manufacturer), selling such old- revamped machines would virtually quadruple profits due to sale of same machine multiple times, the sources said. Selling of replacement machines, to the customer in developed economies and pulling off the old ones under buy back leads to substantial increase in markets beyond borders as the replacement machinery costs much lesser with full re-sale potential.
While such machines do not undergo the transparent type approval process of regulators such as Atomic Energy Regulatory Board (AERB), safety remains a concern for consumers- patients and healthcare providers, the sources said.
Speaking to TOI, a senior radiology technologist said such refurbished machines bomb the doses. Elaborating, he said that by using refurbished equipment, there are higher chances of exposure of radiation beyond prescribed limits.
The economic impact of such imports are severe enough to scuffle the emerging medical devices manufacturing sector, observed Judish Raj, Vice-President (Planning) at Andhra Pradesh MedTech Zone Limited. With no domestic medical device manufacturers being able to compete with refurbished machinery sellers, the mix-up in definition of manufacturers and traders seem to be adding complexity to the issue, believes Manish Gangal, Vice-President (Operations) at AMTZ.
With inter-ministerial task force now looking at limiting the import of selective refurbished medical equipment, the time may be right to see the limited use of re-furbished machines at least in the radiology segment, the sources said.
Stay updated on the go with Times of India News App. Click here to download it for your device.

AiMed Lauds AMTZ For Commencing Booking of Plots

AiMeD feels that there should be incentives for establishing medical devices manufacturing in India.
The Association of Indian Medical Device Industry (AiMeD) has applauded speedy construction of the Andhra Pradesh MedTech Zone (AMTZ) but feels that import duty rationalization is a must to attract investment in the Park.

In a press statement, welcoming the speedy opening up of plot-booking after the formal inauguration of the park sometime back, AiMed has called it an encouraging development but stated that investment to the park will be incentivised only if import duty on medical devices is rationalised. It may be noted that AiMeD was instrumental in visualising the park.

“It will be challenging to populate the park unless EXIM tariff structure is rationalised. Currently, we have nil import duty on most of the electronic medical devices. So, why will anyone invest or take the trouble of setting up manufacturing unit here?” questioned Mr Rajiv Nath, Forum Coordinator, AiMeD.

Mr Nath further pointed out that for items that India has signed under ITA 1 & 2 (Information Technology International Trade Agreements) where it is bound to have nil duty, alternative methods like differential CVD and Excise Duty are required, as is being done for establishing mobile industry. For items for which India has not signed up under ITA -3 the Dept of Revenue needs to apply peak duty of 10%, otherwise why not sign up ITA-3?

Meanwhile, Dr Jitendra Sharma, CEO, AMTZ, has announced the target of closing sale of 300 units in the 270 acres park by 31st December, 2016. “We have already received the first 2 bookings since opening the bookings on October 2, 2016, and the 1st booking was within 6 hours of launch “, he shared.

WASME collaborates with AMTZ to boost MSME in medical device manufacturing

WASME collaborates with AMTZ to boost MSME in medical device manufacturing
Shardul Nautiyal, Mumbai, Friday, September 23, 2016, 08:00 Hrs [IST]

In a major boost to Micro, Small and Medium Enterprises (MSMEs) in medical device industry, the World Association for Small and Medium Enterprises (WASME) has entered into a strategic collaboration with Andhra Pradesh MedTech Zone (AMTZ) as its second industry facilitator at Visakhapatnam which will house the first government funded medical device park in India.

The medical device park will make India an import independent country for medical equipment industry. The collaboration would help setting up a facilitation desk at AMTZ which would act as a one stop shop for all queries of members of WASME.

WASME comes with an international congregation of medium and small scale manufacturers and has a substantial presence in India with a large number of component manufacturers in its fold.

Such strategic associations will act as a catalyst in the confidence building of manufacturers and building a long-term relationship with them. With special focus on MSME manufacturers, WASME provides a global platform for MSMEs to come and set up their units at AMTZ.

After the launch of the Expression of Interest (EOIs) for various common scientific facilities and manufacturing units, these collaborations will bring about required additional stakeholder synergies and interest among the interested manufacturers and/or service providers.

Proposed to be built on 271 acres of land with a seed capital of Rs. 25 crore, AMTZ will set up in-house high capital intensive common scientific facilities helping medical device manufacturers reduce the cost of manufacturing in the country.

The medical device park is proposed to have all such facilities in-house that are required for specialized product verticals to reduce manufacturing process costs. The park will provide modern state-of- the-art common facilities such as specialised laboratories, warehousing and testing centre apart from 150 to 200 independent manufacturing units, each in a built-in ready to use area of 0.5 to 1 acre each.

The AMTZ with in-house high investment scientific facilities would help manufacturers reduce the cost of manufacturing by more than 40 per cent to 50 per cent.

Currently, due to lack of such centrally located shareable facilities, either manufacturers do not undertake production of technologies requiring them or send their products abroad for process up-gradation and value addition.

AMTZ launches EoI for scientific facilities at medical device park in Vishakhapatnam

AMTZ launches EoI for scientific facilities at medical device park in Vishakhapatnam
Shardul Nautiyal, Mumbai , Thursday, September 15, 2016, 08:00 Hrs [IST]

Subsequent to laying of foundation stone on August 19, 2016 by Chief Minister of Andhra Pradesh, N Chandrababu Naidu, Andhra Pradesh MedTech Zone (AMTZ) has recently launched Expression of Interests (EoIs) for scientific facilities for medical equipment manufacturing, project development, construction, set up agencies for enabling technology transfer and financial support at AMTZ in Vishakhapatnam.

The AMTZ Investors’ Brochure was also launched and is available for free download on AMTZ’s website www.AMTZ.in with the Expression of Interest documents for various Common Scientific Manufacturing Facilities. The bookings for factory is set to begin on October 2, 2016.

With 200 to 300 manufacturing units of plot area 0.25 acres, 0.5 acres and 1.0 acre each, AMTZ would host common manufacturing units commonly required for medical equipment manufacturing, tenders of which were released for selection of private agencies under Build & Operate model. These are by far the largest and most comprehensive effort ever made in India to boost the dormant medical devices industry.

Some of these facilities do not exist in India and AMTZ is set to become the first, making India the first country in Asia to host them and also becoming the first in the country to achieve this feat.

Some of the facilities include high-tech laboratories such as component testing and board manufacturing centre, electro-magnetic interference (EMI/EMC) laboratory, medical grade low vacuum molding, cabinet molding, injection molding centres, 3D designing and printing for medical grade products, sterilization and toxicity testing centre, radiation testing centre, gamma irradiation facility, rapid prototyping centre, industrial R&D centre, incubation centre, convention centre and expo halls, warehousing, regulator’s office and other facilities commonly required in manufacturing of medical devices.

These common manufacturing scientific facilities are currently not available in India to most of the manufacturers as they are high in capital investment and the manufacturers instead prefer to send their raw materials abroad for process upgradation. These facilities along with the proximity to all modes of transport like port, railways, road, air will act as unique proposition to attract medical equipment manufacturers to come and set up their units in AMTZ. This shall help reduce cost of manufacturing by over 40 per cent and this benefit could be passed on to the buyers.

India’s first dedicated medical device park initiated in Andhra Pradesh

New Delhi: Andhra Pradesh MedTech Zone, India’s first exclusive medical device manufacturing park is the result of MoU signed between the state government and Association of Indian Medical Devices Industry (AiMeD) nine months back with a view to promote manufacturing of hi-tech and high-end medical devices within the country. The aim is to encourage domestic manufacturing, reduce India’s humungous import dependency in medical devices, generate quality employment and bring down overall healthcare cost for average citizen. The exclusive tech zone will have the state-of-the-art and the best global facilities for R&D, manufacturing, testing, export & regulatory facilitations and logistics.

The Foundation Stone of the 270-acre exclusive manufacturing park was laid on August 19, 2016 at Nadupur village of Pedda Gantyada Mandal in Vishakhapatnam by Andhra Pradesh Chief Minister Mr Chandrababu Naidu in the presence of Union Ministers Mr Venkaih Naidu, Mr Ananth Kumar, Andhra Health Minister Mr Kameini Srinivas, WHO Representative Mr Henk Benkedam, representatives of Indian medical device industry including Mr Rajiv Nath and a galaxy of other notable personalities.

“ We will reduce the cost of healthcare with local production of Medical Devices , We will create common infrastructure for you – the local Industry of world class and assure you of all clearances within 15 days ….” said Mr Chandarababu Naidu

“The AMTZ project will be a game changer for India in the field of Healthcare and is very Good News ! This has global consequences, from being Pharmacy of the World to being the Medical Devices Manufacturing Hub of the World “said WHO India Representative Mr Henk Bekedam

“The launch of AMTZ is the dawn of a new era in the history of Medical Devices and Electronic industry in India. We at AiMeD are extremely happy that our efforts have fructified into this momentous occasion. We profusely thank Shri Chandrababu Naidu and Central Government for sharing our vision and wishing India to be among the top 5 medical device manufacturing hubs of the world. We at AiMeD applaud Mr Naidu’s leadership and his teams for taking steps to turn this into a reality within 9 months of our initial discussions with him last November,” said Mr Rajiv Nath, Forum Coordinator, AiMeD.

“Medical device manufacturing could be the next big thing for Indian economy after the IT revolution. This facility is not only a big milestone for the country which will catapult India into the league of top medical equipment producing countries in the world but equally important it will help bring down overall healthcare cost while ensuring tremendous saving in terms of foreign exchange,” pointed out Mr Nath.

The presence of a galaxy of Union Ministers and State Ministers from Andhra, Senior Officials and who’s who from the medical device industry indicates the support AMTZ and medical devices industry has drawn.

CM lays foundation for ‘AP MedTech Zone’

Vishakhapatnam/New Delhi (INN): The Foundation Stone of India’s first exclusive medical device manufacturing park – Andhra Pradesh MedTech Zone – was laid on Friday at Nadupur village of Pedda Gantyada Mandal in Vishakhapatnam.

The foundation stone was laid by Chief Minister N. Chandrababu Naidu in the presence of Union Ministers M. Venkaiah Naidu and Ananth Kumar, AP Health Minister Kamineni Srinivas, WHO Representative Henk Benkedam, representatives of Indian medical device industry including Rajiv Nath and a galaxy of other notable personalities.

AMTZ, the 270-acre exclusive manufacturing zone is the result of MoU signed between the state government and AiMeD nine months back with a view to promote manufacturing of hi-tech and high-end medical devices within the country with a view to encourage domestic manufacturing, reduce India’s humungous import dependency in medical devices, generate quality employment and bring down overall healthcare cost for average citizen. The exclusive tech zone will have the state-of-the-art and the best global facilities for R&D, manufacturing, testing, export & regulatory facilitations and logistics.

‘ We will reduce the cost of healthcare with local production of Medical Devices , We will create common infrastructure for you – the local Industry of world class and assure you of all clearances within 15 days” said Chandarababu Naidu.

“The AMTZ project will be a game changer for India in the field of Healthcare and is very Good News ! This has global consequences, from being Pharmacy of the World to being the Medical Devices Manufacturing Hub of the World “said WHO India Representative Henk Bekedam

‘The launch of AMTZ is the dawn of a new era in the history of Medical Devices and Electronic industry in India. We at AiMeD are extremely happy that our efforts have fructified into this momentous occasion. We profusely thank Chandrababu Naidu and Central Government for sharing our vision and wishing India to be among the top 5 medical device manufacturing hubs of the world. We at AiMeD applaud Chandrababu Naidu’s leadership and his teams for taking steps to turn this into a reality within 9 months of our initial discussions with him last November,’ said Rajiv Nath, Forum Coordinator, AiMeD.

‘Medical device manufacturing could be the next big thing for Indian economy after the IT revolution. This facility is not only a big milestone for the country which will catapult India into the league of top medical equipment producing countries in the world but equally important it will help bring down overall healthcare cost while ensuring tremendous saving in terms of foreign exchange,’ pointed out Nath.

Naidu lays foundation stone for AP MedTech zone in Vizag

Vishakhapatnam, 19th Aug : The Foundation Stone of India’s first exclusive medical device manufacturing park – Andhra Pradesh MedTech Zone – was laid today at Nadupur village of Pedda Gantyada Mandal in Vishakhapatnam by Andhra Pradesh Chief Minister Shri Chandrababu Naidu in the presence of Union Ministers Shri Venkaih Naidu, Shri Ananth Kumar, Andhra Health Minister Shri Kameini Srinivas, WHO Representative Mr Henk Benkedam, representatives of Indian medical device industry including Shri Rajiv Nath and a galaxy of other notable personalities.

AMTZ, the 270-acre exclusive manufacturing zone is the result of MoU signed between the state government and AiMeD with a view to promote manufacturing of hi-tech and high-end medical devices within the country. It aims to encourage domestic manufacturing, reduce India’s humungous import dependency in medical devices, generate quality employment and bring down overall healthcare cost for average citizen. The exclusive tech zone will have the state-of-the-art and the best global facilities for R&D, manufacturing, testing, export & regulatory facilitations and logistics.

” We will reduce the cost of healthcare with local production of Medical Devices , we will create common infrastructure for you – the local Industry of world class and assure you of all clearances within 15 days ….” said Mr Chandarababu Naidu

“The AMTZ project will be a game changer for India in the field of Healthcare and is very Good News ! This has global consequences, from being Pharmacy of the World to being the Medical Devices Manufacturing Hub of the World “said WHO India Representative Mr Henk Bekedam

“Medical device manufacturing could be the next big thing for Indian economy after the IT revolution. This facility is not only a big milestone for the country which will catapult India into the league of top medical equipment producing countries in the world but also help bring down overall healthcare cost while ensuring tremendous saving in terms of foreign exchange,” said Mr Rajiv Nath, Forum Coordinator, AiMeD.

Foundation Stone of India’s First Dedicated Medical Device Park “AP MedTech Zone” laid!

Vishakhapatnam/New Delhi : The Foundation Stone of India’s first exclusive medical device manufacturing park – Andhra Pradesh MedTech Zone – was laid today at Nadupur village of Pedda Gantyada Mandal in Vishakhapatnam by Andhra Pradesh Chief Minister Shri Chandrababu Naidu in the presence of Union Ministers Shri Venkaih Naidu, Shri Ananth Kumar, Andhra Health Minister Shri Kameini Srinivas, WHO Representative Mr Henk Benkedam, representatives of Indian medical device industry including Shri Rajiv Nath and a galaxy of other notable personalities.
CM Chandrababu Naidu along with Venkaih Naidu, Ananth Kumar, YS Chaudhary and WHO Representative Mr Henk Benkedam lays the foundation of exclusive park near Vishakhapatnam.
It’s a big milestone for the country and especially for the medical device industry. We at AiMeD are extremely happy that our efforts have fructified into this momentous occasion. This facility will help India catapult into the league of top medical equipment producing countries in the world and help bring down overall healthcare cost while ensuring tremendous saving in terms of foreign exchange -Rajiv Nath
Medical device manufacturing could be the next big thing for Indian economy after the IT revolution – Rajiv Nath
AMTZ, the 270-acre exclusive manufacturing zone is the result of MoU signed between the state government and AiMeD nine months back with a view to promote manufacturing of hi-tech and high-end medical devices within the country with a view to encourage domestic manufacturing, reduce India’s humungous import dependency in medical devices, generate quality employment and bring down overall healthcare cost for average citizen. The exclusive tech zone will have the state-of-the-art and the best global facilities for R&D, manufacturing, testing, export & regulatory facilitations and logistics.
“ We will reduce the cost of healthcare with local production of Medical Devices , We will create common infrastructure for you – the local Industry of world class and assure you of all clearances within 15 days ….” said Mr Chandarababu Naidu
“The AMTZ project will be a game changer for India in the field of Healthcare and is very Good News ! This has global consequences, from being Pharmacy of the World to being the Medical Devices Manufacturing Hub of the World “said WHO India Representative Mr Henk Bekedam
“The launch of AMTZ is the dawn of a new era in the history of Medical Devices and Electronic industry in India. We at AiMeD are extremely happy that our efforts have fructified into this momentous occasion. We profusely thank Shri Chandrababu Naidu and Central Government for sharing our vision and wishing India to be among the top 5 medical device manufacturing hubs of the world. We at AiMeD applaud Mr Naidu’s leadership and his teams for taking steps to turn this into a reality within 9 months of our initial discussions with him last November,” said Mr Rajiv Nath, Forum Coordinator, AiMeD.
“Medical device manufacturing could be the next big thing for Indian economy after the IT revolution. This facility is not only a big milestone for the country which will catapult India into the league of top medical equipment producing countries in the world but equally important it will help bring down overall healthcare cost while ensuring tremendous saving in terms of foreign exchange,” pointed out Mr Nath.
The presence of a galaxy of Union Ministers and State Ministers from Andhra, Senior Officials and who’s who from the medical device industry indicates the support AMTZ and medical devices industry has drawn.
About AMTZ:
• Only the third such exclusive facility for manufacturing of medical devices in the world.
• A great example of public-private cooperation, the result of an idea mooted by AiMeD and endorsed fully by Shri Chandrababu Naidu and fully supported by Central government.
• Spread over 270 acres at Pedda Gantyada Mandal in Vishakhapatnam within close vicinity of Vizag international port.
• Will house over 200 medical devices manufacturing units.
• Will have R&D, testing, logistics, regulatory facilities within the campus.
• Will have common manufacturing facilities, plug & play modeled, ready to move in built-up, pre-approved and Factory Act compliant factories.
About AiMeD: AIMED is an umbrella association of Indian manufacturers of medical devices covering all types of medical devices including consumables, disposables, equipments, Implants, instruments and diagnostics. AIMED has a primary membership of over 350 manufacturers and additionally of over 150 associate members representing the interest of over 700 manufacturers of medical devices to address the manufacturer’s problems. To know more about AIMED, please visit www.aimedindia.com

AP CM lays foundation for Medical Tech Park

The park will come up in an area of 226 acres of land allotted by the State at Nadupuru in Peda Gantyada mandal.

Andhra Pradesh Chief Minister, N. Chandrababu Naidu on Friday laid foundation stone for A P Medical Technology Park, India’s first dedicated medical devices manufacturing park, near here.

The park will come up in an area of 226 acres of land allotted by the State at Nadupuru in Peda Gantyada mandal. Over 200 units are expected with a potential to provide employment to to 25,000 people.

Mr. Naidu said this is the first of its kind park in South Asia. The project to be implemented by AP Med Tech Zone will bring down the cost of healthcare substantially by reducing dependency on imported devices and equipment.

An investment of Rs. 225 crore will be made to create in-house common facilities like scientific labs and warehouses. Health Minister Kamineni Srinivas said 38 firms have intimated expression of interest to set up units in the park.

Foundation stone of India’s first exclusive medical device manufacturing park laid

The 270-acre Andhra Pradesh MedTech Zone will have state-of-the-art and the best global facilities for R&D, manufacturing, testing, export and regulatory facilitations and logistics

The foundation stone of India’s first exclusive medical device manufacturing park, Andhra Pradesh MedTech Zone (AMTZ), was laid at Nadupur village of Pedda Gantyada Mandal in Vishakhapatnam by Chandrababu Naidu, Chief Minister, Andhra Pradesh. Also present were Union Ministers Venkaiah Naidu, Ananth Kumar, Kameini Srinivas, Health Minister, Andhra Pradesh, Henk Bekedam, WHO Representative to India and representatives from Indian medical device industry. Rajiv Nath, Forum Coordinator, AiMeD was also present during the event.

AMTZ, the 270-acre exclusive manufacturing zone is the result of MoU signed between the state government and AiMeD nine months back with a view to promote manufacturing of high-tech and high-end medical devices within the country. The zone will have state-of-the-art and the best global facilities for R&D, manufacturing, testing, export and regulatory facilitations and logistics. It will house 200 medical devices manufacturing units.

“The AMTZ project will be a game changer for India in the field of healthcare. This has global consequences, from being Pharmacy of the World to being the Medical Devices Manufacturing Hub of the World,” said Bekedam.

“The launch of AMTZ is the dawn of a new era in the history of medical devices and electronic industry in India. “Medical device manufacturing could be the next big thing for Indian economy after the IT revolution. This facility is not only a big milestone for the country which will catapult India into the league of top medical equipment producing countries in the world but equally important it will help bring down overall healthcare cost while ensuring tremendous saving in terms of foreign exchange,” said Rajiv Nath, Forum Coordinator, AiMeD.

EH News Bureau

Country’s First Medical Device Park “A dream Come true “ Andhra Pradesh CM,Naidu laid foundation stone

• CM Chandrababu Naidu along with Venkaih Naidu, Ananth Kumar, YS Chaudhary,Dr.Jitendar sharma(CEO,AMTZ) WHO Representative Mr Henk Benkedam lays the foundation of exclusive park near Vishakhapatnam.
• It’s a big milestone for the country and especially for the medical device industry. We at AiMeD are extremely happy that our efforts have fructified into this momentous occasion. This facility will help India catapult into the league of top medical equipment producing countries in the world and help bring down overall healthcare cost while ensuring tremendous saving in terms of foreign exchange – Rajiv Nath

• Medical device manufacturing could be the next big thing for Indian economy after the IT revolution – Rajiv Nath

Vishakhapatnam : The Foundation Stone of India’s first exclusive medical device manufacturing park – Andhra Pradesh MedTech Zone – was laid today at Nadupur village of Pedda Gantyada Mandal in Vishakhapatnam by Andhra Pradesh Chief Minister Shri Chandrababu Naidu in the presence of Union Ministers Shri Venkaih Naidu, Shri Ananth Kumar, Andhra Health Minister Shri Kameini Srinivas, WHO Representative Mr Henk Benkedam, representatives of Indian medical device industry including Shri Rajiv Nath and a galaxy of other notable personalities.

AMTZ, the 270-acre exclusive manufacturing zone is the result of MoU signed between the state government and AiMeD nine months back with a view to promote manufacturing of hi-tech and high-end medical devices within the country with a view to encourage domestic manufacturing, reduce India’s humungous import dependency in medical devices, generate quality employment and bring down overall healthcare cost for average citizen. The exclusive tech zone will have the state-of-the-art and the best global facilities for R&D, manufacturing, testing, export & regulatory facilitations and logistics.

“ We will reduce the cost of healthcare with local production of Medical Devices , We will create common infrastructure for you – the local Industry of world class and assure you of all clearances within 15 days ….” said Mr Chandarababu Naidu “The AMTZ project will be a game changer for India in the field of Healthcare and is very Good News ! This has global consequences, from being Pharmacy of the World to being the Medical Devices Manufacturing Hub of the World “said WHO India Representative Mr Henk Bekedam

AMTZ will reduce import dependency and promote exports in manner that is unprecedented – said CEO of AMTZ Dr Jitendar Sharma who is leading this project from the forefront. The senior team consists of some of the best minds in the space – Dr Pankaj Parashar( VP- technical); Manish Gangal ( VP- operations); Deepak Agarkhed ( VP- Planning) ; Vipin Ramachandran ( VP- Finance) and Nitin Bharadwaj ( VP-HR and Admin) “The launch of AMTZ is the dawn of a new era in the history of Medical Devices and Electronic industry in India. We at AiMeD are extremely happy that our efforts have fructified into this momentous occasion. We profusely thank Shri Chandrababu Naidu and Central Government for sharing our vision and wishing India to be among the top 5 medical device manufacturing hubs of the world. We at AiMeD applaud Mr Naidu’s leadership and his teams for taking steps to turn this into a reality within 9 months of our initial discussions with him last November,” said Mr Rajiv Nath, Forum Coordinator, AiMeD.

“Medical device manufacturing could be the next big thing for Indian economy after the IT revolution. This facility is not only a big milestone for the country which will catapult India into the league of top medical equipment producing countries in the world but equally important it will help bring down overall healthcare cost while ensuring tremendous saving in terms of foreign exchange,” pointed out Mr Nath.

The presence of a galaxy of Union Ministers and State Ministers from Andhra, Senior Officials and who’s who from the medical device industry indicates the support AMTZ and medical devices industry has drawn.

Pharma SMEs need boost like 25 per cent Capital Subsidy | Dr Jitendar Sharma, CEO, AMTZ

Recently, FDI in Brownfield (existing units) pharma sector has been permitted upto 74% under automatic route; and FDI beyond 74% and upto 100% is allowed under Government approval route. The move is aimed at attracting required capital, international best practices and latest technologies in the sector. Further, 100% FDI under automatic route is permitted for Greenfield (new plant) pharma sector. The Commerce and Industry Ministry has also commissioned a study to assess the impact of foreign direct investment in pharmaceutical companies amid concerns over mergers and acquisitions of domestic drug manufacturers.

But will it really help? Whether government be able to fulfill its wish? What has been the experience of FDI in medical sector? In January 2015 government opened up 100 per cent FDI for Medical devices. Did it help to meet the country’s medical devices’ demand which include sutures, stents, implants etc?

SMEpost.com caught up with Dr. Jitendar Sharma, head of Health Technology Department under Ministry of Health & Family Welfare, Govt. of India who is also CEO of Andhra Med Tech Zone (AMTZ), for a candid chat on what has been impact so far 100 % FDI in Medical devices?

Here are the excerpts….

Q: What is the impact of 100% FDI in medical devices through the automatic route?

A: Foreign direct investment is an important source of capital. While FDI through FIPB route leads to capital influx through government approval process, 100% FDI via direct route simplifies investment process. While process is simple, it is also necessary to keep FDI’s purpose simplified. The role of the government is that of a benefactor for process simplification, capital promotion and economic solidification. However, its policies affect medical devices manufacturing industry. While FDI via direct route is growing, it remains to be seen whether such investments would lead to Greenfield investments or Brownfield takes over, mergers & acquisitions. While the former is certainly encouraging the R & D, the latter could lead to domestic industry wipe outs. The path of FDI therefore requires constant monitoring and policy corrections, as and when required.

Q: Has it really boosted the SMEs?

A: SMEs are always in a financial crunch, an easy funding from FDI can boost the industry by some less intense financial infusion. However, such boosts need to be well managed by smooth integration of SME specific fiscal policies such as 25% capital subsidy among others.

Q: About 60 to 70% of the country’s medical devices’ demand, which include sutures, implants and surgical instruments, is met through imports. So why is India lagging behind in medical device sector?

A: Medical device manufacturing in India lacks a thrust due to absence of scientific facilities that are capital intensive in nature. While such facilities remain beyond the ambit of small to moderate manufacturing units due to sheer capital crunch, efforts to create such facilities have been negligible.

A special mention should go AMTZ – Andhra Pradesh Med Tech Zone, a one of its kind initiative in the Country and even Asia, where the Government is creating conducive environments for the manufacturers of medical devices by providing them with developed lands and constructed units with in-house shared High-tech Common manufacturing, testing and QA facilities of the best in the world standards. This facility as in AMTZ would drastically bring down the manufacturing cost of the medical devices – up to 70-75 per cent in certain cases – and hence the products manufactured in India would be of the ‘Best Quality and the least price’. This AMTZ once developed can easily churn out an approximate turnover of more than 30,000 Crore annually.

The perspective of the buyers is also changing very fast. We Indians now find it a matter of pride to use indigenous products over the imported ones. Medical Devices are no exception to this.

The Med–Tech Start-ups are now being very much supported and are being brought into the main arena where they fight with their aggressive pace, passion and Technological uniqueness with the Giants.

India is very soon going to be the “Hot Spot” for Medical Device Innovation, Research & Development, Manufacturing and Exports. The Government is soon trying to match the pace with the industry in easing out the laws and properly defining the regulatory aspects.

Q: Earlier, there was no separate policy for medical devices, which were covered under pharmaceuticals. The pharma policy imposed stiff foreign investment conditions, including mandatory government approvals in case of Brownfield investment or stake acquisition in existing Indian companies. But now both sector are separated and have different policy regarding FDI. So will it make any impact even if they don’t work together?

A: The Medical Device Industry once separated from the pharma sector gets a fresh air to breathe. The new open space with an open FDI option will certainly provide the very much required financial thrust that the medical device manufacturers need, as this is a highly capital intensive sector to stay ahead in the race. This however, needs to balance in a way that FDI flows into Greenfield projects and core R & D activities. The apt mega projects like the AMTZ – Visakhapatnam, will really provide the immensely required boost so that medical devices manufactured in India will be as good as a device made in Germany, USA or anywhere else.

Q: Being CEO of AMTZ, what has been your experience so far working with the SMEs? What has been the learning from the same?

A: As an innovator in the Medical Technology space, I feel the times to come in India are very bright for the Medical Device sector. The Government is doing a lot and has great plans for the future. But what is need is a smart execution. The Manufacturers are more than happy to “Make in India.” The Health ministry hosts a Healthcare Innovation Portal with various incubators and support agencies to nurture the innovations in health care. In the very near future, India is going to become a favorite destination for the best quality medical device manufacturing. The efforts into creating AMTZ bring us the peep into practical requirements of Indian Medical Devices manufacturing sector, in particular the SME segment.

I personally feel that for any med-tech Innovator, this is the time to be in this sector and these efforts truly indicate Medical Devices as the sun rise sector of our country.

Andhra Med Tech Zone team visits Shanghai

Andhra Med Tech Zone is in the process of finalizing its project report and to ensure that global best practices are incorporated, the delegation led by the Health Minister visited Shanghai.

Shanghai, 19 July : A delegation led by Andhra Pradesh, Health Minister Dr. Kamaneni Srinivas along with Principal Health Secretary, Dr. Poonam Malakondaiah and CEO Andhra Med Tech Zone ( AMTZ) Dr. Jitendar Sharma visited Shanghai International Medical Zone to study the medical device manufacturing industry practices in China. The delegation was accompanied by KPMG which is making the detailed project report for AMTZ.

As part of the visit, the delegation visited analogics- worlds most popular component and board manufacturers as well as Shanghai testing and inspection Institute for medical devices along with a number of manufacturing units and common facilities located within the zone.

Keeping in view the AP Govt initiative to establish India’s first medical device manufacturing zone in Andhra Pradesh, the visit has been made to ensure that Andhra Med Tech zone carries the best practices and world-class infrastructure right from the stage of planning.

AMTZ opens Detailed Project Report opportunity for Global Cos.

Andhra Med Tech Zone Ltd. (AMTZ) in its marathon target to be the first of its kind medical equipment manufacturing hub, has cleared another major milestone- with the release of RFP for selection project consultancy firm for preparing a Detailed Project Report (DPR). The RFP for DPR agency was released on 3rd of June and a pre-bid meeting with Industrial Partners was held on 17th June at Visakhapatnam.

While champions in industrial designing and infra-tech development are expected to participate in the preparation of DRP for the prestigious project, no effort would be spared in getting technical excellence to design and implement the project- said Dr. Jitendar Sharma, the Chief Executive Office of AMTZ Ltd.

Andhra Pradesh health department has formally taken over 226 acres of land to set up Asia’s first dedicated medical device park at Visakhapatnam. A seed capital of Rs.25 crore has also been given by the government, according to a source associated with the development. AMTZ is proposed to have in-house high investment scientific facilities that would help manufacturers reduce the cost of manufacturing and is first of its kind in Asia as it aims to flourish as a hub of medical device manufacturing, putting India on the global map of high end medical equipment production and make health care products affordable and accessible.

AMTZ gets capital, land for Asia’s first dedicated medical device park at Visakhapatnam

Subsequent to a recent visit of board of directors to the Andhra Med Tech Zone (AMTZ) site, Andhra Pradesh health department has formally taken over 226 acres of land to set up Asia’s first dedicated medical device park at Visakhapatnam. A seed capital of Rs.25 crore for the land has also been given by the government, according to a source associated with the development.

Andhra Med Tech Zone (AMTZ), a company under government of Andhra Pradesh which has also received approval for funding on 1st June, 2016 from the state cabinet will implement the project of setting up the park.

AMTZ will set up in-house high capital intensive common scientific facilities helping medical device manufacturers reduce the cost of manufacturing in the country.

Over 50 companies have shown interest and 38 companies have submitted Expression of Interest (EOI) letters subsequent to Andhra Pradesh government inviting EOI letters from potential investors.

Andhra Pradesh government has also issued appointment orders for Dr Jitendar Sharma, head of health technology department at National Health Systems Resource Centre (NHSRC) under the Union health ministry and advisor – health and medical technology to government of Andhra Pradesh to be the chief executive officer for the AMTZ project.

The medical device park is proposed to have all such facilities in-house that are required for specialized product verticals to reduce manufacturing process costs. The park will provide modern state of art common facilities such as specialised laboratories, warehousing, testing centre apart from 100 to 150 independent manufacturing units, each in a built-in ready to use area of 0.5 to 1 acre each.

A dedicated medical devices park would be of immense help in reducing import dependency, increasing export while generating wealth and employment within the country.

Indian medical device industry is worth over Rs.60,000 crore and country’s import bill for this segment amounts to over Rs.23,000 crore while export amounts to only over Rs.7,000 crore. India’s import dependency on high-end medical devices is over 80 per cent and 60 per cent to 70 per cent for other devices.

Gujarat govt allocates land for setting up medical device park at Sanand

Subsequent to Union minister of chemicals and fertilisers Ananth Kumar announcement for setting up medical devices and pharma parks in Gujarat, Gujarat government has finally identified and allocated the land for the same at Sanand near Ahmedabad.

Detailed Project Report (DPR) has also been submitted and a favourable response has been awaited on the same from the Centre, informed an official associated with the development.

The Centre has been mulling for quite some time now for setting up the medical devices park in Gujarat in a bid to make India self-reliant in the sector. Union minister of chemicals and fertilisers had in the past sought cooperation from the state government to implement the project and the latter responded positively in terms of providing land for them.

Gujarat Food and Drug Control Administration (FDCA) commissioner Dr H G Koshia said, “Getting land is a positive development in this direction. A medical device park is also very much relevant for Gujarat as the state has the largest number of 135 licensed medical device companies as against 240 in the entire country which are nurtured by Gujarat FDCA with an exemplary approach and has received recognition in the country.”

He explained government’s plan to set up medical device parks will bring about quality, compliance and provide cost effectiveness in the industry by providing infrastructure to boost medical device manufacturing in India.

“NIPER Ahmedabad is also being developed as a national centre of excellence for medical devices which will provide a conducive environment to nurture innovators and industry to further the vision of quality medical device manufacturing in the country through synergies with the government and other stake holders,” Koshia added.

The creation of manufacturing park for medical devices is the need of the hour as medical devices manufacturing requires certain high investment facilities which are too capital intensive for individual manufacturers to invest upon. A park with in-house high investment scientific facilities would help manufacturers reduce the cost of manufacturing by more than 40 per cent to 50 per cent.

Currently, due to lack of such centrally located common facilities, manufacturers do not undertake production of technologies and therefore send their products abroad for process up-gradation and value addition.

This will also help facilitate to create an ecosystem for manufacturing of high end medical device manufacturing aimed at import substitution and export opportunities and would be a major boost to SMEs.

Meanwhile, Andhra Med Tech Zone (AMTZ), a company established under government of Andhra Pradesh has also received approval for funding by the state cabinet for setting up a dedicated medical device park at Visakhapatnam in Andhra Pradesh.

A dedicated medical devices park would be of immense help in reducing import dependency, increasing export while generating wealth and employment within the country.

AP govt approves funding for Asia’s first medical device park at Visakhapatnam

Andhra Med Tech Zone (AMTZ), a company established under government of Andhra Pradesh has finally received approval for funding by the state cabinet on 1st June, 2016 for setting up Asia’s first dedicated medical device park at Visakhapatnam in Andhra Pradesh.

A dedicated medical devices park would be of immense help in reducing import dependency, increasing export while generating wealth and employment within the country.

AMTZ which got formal registration recently towards making India a global medical device manufacturing hub is proposed to have in-house high investment scientific facilities in an area of 226 acres helping medical device manufacturers reduce the cost of manufacturing.

Andhra Pradesh Government has also issued appointment orders for Dr Jitendar Sharma, head of health technology department at National Health Systems Resource Centre (NHSRC) under the Union Health Ministry and Advisor – Health and Medical Technology to Government of Andhra Pradesh to be the chief executive officer for the AMTZ project. AMTZ is the brainchild of Dr Sharma who has also been associated with implementation of several health technology intensive projects in the country and is known in technology circles as the Med Tech Man of India.

The medical device park is proposed to have all such facilities in-house that are required for specialized product verticals to reduce manufacturing process costs. The park will provide modern state of art common facilities such as specialised laboratories, warehousing, testing centre apart from 100 to 150 independent manufacturing units, each in a built-in ready to use area of 0.5 to 1 acre each.

Established subsequent to announcement made by the Andhra Pradesh Chief Minister Chandrababu Naidu after a series of consultations with Indian medical device manufacturing industry, AMTZ aims to flourish as a hub of medical device manufacturing putting India on the global map of high end medical equipment production and make health care products affordable and accessible.

The creation of manufacturing park for medical devices is the need of the hour as medical devices manufacturing requires certain high investment facilities which are too capital intensive for individual manufacturers to invest upon. A park with in-house high investment scientific facilities would help manufacturers reduce the cost of manufacturing by more than 40 per cent to 50 per cent.

Currently, due to lack of such centrally located common facilities, manufacturers do not undertake production of technologies and therefore send their products abroad for process upgradation and value addition.

It will help facilitate to create an ecosystem for manufacturing of high end medical device manufacturing aimed at import substitution and export opportunities and would be a major boost to SMEs.

Indian medical device industry is worth over Rs.60,000 crore and country’s import bill for this segment amounts to over Rs.23,000 crore while export amounts to only over Rs.7,000 crore. India’s import dependency on high-end medical devices is over 80 per cent and 60 per cent to 70 per cent for other devices.

Dr. Jitendar Sharma appointed as Andhra Med Tech Zone CEO

Andhra Med Tech Zone (AMTZ) on Wednesday received approval for funding by the state cabinet. AMTZ is proposed to have in-house high investment scientific facilities that would help manufacturers reduce the cost of manufacturing and is first of its kind in Asia.

State Government on 1st June also issued appointment orders for Dr. Jitendar Sharma, the head of health technology department at NHSRC under Ministry of Health & Family Welfare, Govt. of India and the advisor – health & medical technology to Government of Andhra Pradesh to be the Chief Executive Officer for the AMTZ project, who has been the brain behind the project.

Dr Sharma comes with an exhaustive experience of supporting the entire range of healthcare delivery systems-from a primary health centre to World Health Organization.

Earlier, he had served as hospital administrator at Sri Sathya Sai Baba’s free hospital in Andhra Pradesh. He is known for leading several projects and health technology and research studies in leading institutions from AIIMS New Delhi to WHO- Switzerland.

Andhra Med Tech Zone aims to flourish as a hub of medical device manufacturing, putting India on the global map of high end medical equipment production and make health care products affordable and accessible.

Asia’s first medical-device park

Andhra Med Tech Zone (AMTZ) — a company established by the government in the Indian state of Andhra Pradesh — has received the formal registration that will kick-start establishing Asia’s first dedicated medical-device park.

Located in 226 acres at Visakhapatnam, the park will have all the facilities required to ensure optimised manufacturing costs, including specialised laboratories, warehousing and testing centres, as well as
100-150 independent manufacturing units.

Medical-device development and manufacturing requires certain high-cost facilities that are too capital-intensive for individual manufacturers to justify, but a park with in-house ‘high-investment’ scientific facilities could help manufacturers reduce the cost of manufacturing by as much as 50% — or possibly more.

The centrally located common facilities as proposed by AMTZ will support the manufacture of high-end medical devices aimed not only at import substitution but also at creating export opportunities.

India’s medical-device industry is worth about $9 billion; the country’s import bill for this segment is about $3.45 billion, so a dedicated medical-device park would significantly reduce import dependency and increase exports (currently a little over $1 billion), while generating wealth and employment.

Andhra Med Tech Zone gets formal registration to set up Asia’s first dedicated medical devices park

Andhra Med Tech Zone (AMTZ)- company established under government of Andhra Pradesh has finally received formal registration which will kick start establishing Asia’s first dedicated medical device park in an area of 226 acres at Visakhapatnam in Andhra Pradesh.

The park is proposed to have all such facilities in-house that are required for specialized product verticals to reduce manufacturing process costs. The park will provide for modern state of art common facilities such as specialised laboratories, warehousing, testing centre apart from 100 to 150 independent manufacturing units, each in a built-in ready to use area of 0.5 to 1 acre each.

Established subsequent to announcement made by Andhra Pradesh chief minister Chandrababu Naidu after a series of consultations with Indian medical device manufacturing industry, AMTZ is the brainchild of Dr Jitendar Sharma, head of health technology department of National Health Systems Resource Centre (NHSRC) and also advisor to chief minister of Andhra Pradesh for health and medical technology.

The creation of manufacturing park for medical devices is the need of the hour as medical devices manufacturing requires certain high investment facilities which are too capital intensive for individual manufactures to invest upon. A park with in-house high investment scientific facilities would help manufacturers reduce the cost of manufacturing by more than 40 per cent to 50 per cent.

Currently, due to lack of such centrally located common facilities, manufacturers do not undertake production of technologies and therefore send their products abroad for process upgradation and value addition.

It will help facilitate to create an ecosystem for manufacturing of high end medical device manufacturing aimed at import substitution and export opportunities and would be a major boost to SMEs.

Indian medical device industry is worth over Rs. 60,000 crore and country’s humongous import bill for this segment amounts to over Rs. 23,000 crore while export amounts to only over Rs. 7,000 crore. India’s import dependency on high-end medical devices is over 80 per cent and 60 per cent to 70 per cent for other devices. And this is where the dedicated medical device park would be of great value – reducing humongous import dependency, increasing export while generating wealth and employment within.